Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
The mean glucose level over 24-hours at Baseline and Day 13 was determined using CGM values corrected for participant-administered finger-stick values. LS mean values were derived from a constrained longitudinal analysis model. A negative (-) change from Baseline to Day 13 indicates improvement of the assessed outcome. (NCT02318693)
Timeframe: Baseline (Day -2) and Day 13
MAGE is a popular metric for assessment of major (e.g., postprandial) glucose swings. MAGE is calculated as the average of differences between consecutive glucose peaks and nadirs greater than 1 standard deviation (SD) of 24-hour mean glucose. In this assessment, glucose levels were determined using continuous glucose monitoring (CGM) over 24 hours at Baseline and Day 13; CGM values were further corrected for blood glucose values obtained via participant-administered finger-stick. Least squares (LS) means values were derived from a constrained longitudinal analysis model. A negative (-) change from Baseline to Day 13 indicates improvement of the assessed outcome. (NCT02318693)
Timeframe: Baseline (Day -2) and Day 13
SD is a popular metric for assessment of postprandial glucose swings. The SD of all glycemic excursions over 24 hours (i.e., total of 288 glucose values over 24 hours) was determined for Baseline and Day 13. Original values were obtained using CGM and corrected for blood glucose values obtained via participant-administered finger-stick. LS mean values were derived from a constrained longitudinal analysis model. A negative (-) change from Baseline to Day 13 indicates improvement of the assessed outcome. (NCT02318693)
Timeframe: Baseline (Day -2) and Day 13
The peak postprandial glucose level during the 3 hours post meal minus the preprandial glucose level 1 hour before meal was determined for corrected CGM values at Baseline and Day 13 for breakfast, lunch, and dinner. Meals were standardized with respect to total calories, and protein, fat, and carbohydrate composition as well as timing of administration. CGM values were corrected using a participant-administered finger-stick test for blood glucose. LS mean values were derived from a constrained longitudinal analysis model. A negative (-) change from baseline to Day 13 indicates better control of postprandial glucose. (NCT02318693)
Timeframe: Baseline (Day -2) and Day 13
Hypoglycemia, defined as low blood glucose, is a common side effect of medications used to treat diabetes mellitus type 2. The percentage of hypoglycemic corrected CGM readings (sensor glucose <70, <60, <50 mg/dL) over a 24-hour period were determined at baseline and Day 13. CGM values were corrected using a participant-administered finger-stick test for blood glucose. LS mean values were derived from a constrained longitudinal analysis model. A negative (-) change from baseline to Day 13 indicates improvement in occurrence of hypoglycemia. (NCT02318693)
Timeframe: Baseline (Day -2) and Day 13
Battery of neuropsychometric tests to evaluate a variety of cognitive functions. (NCT00597545)
Timeframe: Post-operatively at 1 day
Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which are hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness. (NCT00121667)
Timeframe: AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla
'Confirmed' = recorded on the hypoglycemia AE case report form with a fingerstick glucose <= 50 mg/dL and associated symptoms. (NCT00121667)
Timeframe: AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla
The normality/abnormality of the ECG tracing was determined by the investigator. (NCT00121667)
Timeframe: Baseline, Weeks 12, 24, 76, 102, 154, 206,
A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: <0.9 x Pre-Rx & <=130mEq/L / high: >1.1 x Pre-Rx & >=150mEq/L; potassium, serum low: <=0.8 x Pre-Rx & >=6.0mEq/L / high: 1.2 x Pre-Rx & >=6.0mEq/L; LLN=lower limit of normal. (NCT00121667)
Timeframe: Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure: 124, 118, 130, 95 weeks, respectively, for 2.5mg, 5mg, 10 mg, placebo.
AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing. (NCT00121667)
Timeframe: AEs: up to last treatment day + 1 day or last visit day in the ST+LT period; SAEs: up to last treatment day + 30 days or last visit day + 30 days in the LT+ST period. Mean duration of exposure: 124, 118, 130, 95 wks respectively for 2.5mg, 5mg, 10 mg, pla
Percentage of participants achieving A1C < 7%, the American Diabetic Association's defined goal for glycemia, at each dose of saxagliptin plus TZD versus placebo plus TZD at Week 24. (NCT00295633)
Timeframe: Week 24
Mean change from baseline for 0 to 180 minutes PPG AUC achieved at each dose of saxagliptin plus TZD versus placebo plus TZD at Week 24, adjusted for baseline value. (NCT00295633)
Timeframe: Baseline, Week 24
Percentage of participants achieving A1C < 7%, the American Diabetes Association's defined goal for glycemia, at each dose of saxagliptin plus metformin versus metformin alone at Week 24. (NCT00327015)
Timeframe: Week 24
Percentage of participants achieving A1C < 7%, the American Diabetes Association's defined goal for glycemia, at each dose of saxagliptin plus metformin versus saxagliptin alone at Week 24. (NCT00327015)
Timeframe: Week 24
Percentage of participants achieving A1C ≤6.5%, at each dose of saxagliptin plus metformin versus metformin alone at Week 24. (NCT00327015)
Timeframe: Week 24
Percentage of participants achieving A1C ≤6.5%, at each dose of saxagliptin plus metformin versus saxagliptin alone at Week 24. (NCT00327015)
Timeframe: Week 24
Percentage of participants requiring rescue for failing to achieve pre-specified glycemic targets or discontinuing for lack of efficacy within the 24-week treatment period at each dose of saxagliptin plus metformin versus metformin alone. (NCT00327015)
Timeframe: Week 24
Percentage of participants requiring rescue for failing to achieve pre-specified glycemic targets or discontinuing for lack of efficacy within the 24-week treatment period at each dose of saxagliptin plus metformin versus saxagliptin alone. (NCT00327015)
Timeframe: Week 24
Mean change from baseline for 0 to 180 minutes PPG AUC at Week 24, adjsuted for baseline value. (NCT00327015)
Timeframe: Baseline, Week 24
Mean change from baseline for 0 to 180 minutes PPG AUC at Week 24, adjusted for baseline value. (NCT00327015)
Timeframe: Baseline, Week 24
Percentage of participants achieving A1C < 7%, the American Diabetes Association's defined goal for glycemia, at each dose of saxagliptin plus glyburide versus placebo plus upward titrated glyburide at Week 24. (NCT00313313)
Timeframe: Week 24
Mean change from baseline for 0 to 180 minutes PPG AUC at Week 24, adjusted for baseline values. (NCT00313313)
Timeframe: Baseline, Week 24
The change between Body Weight measured at week 12 and Body Weight measured at baseline. (NCT00286468)
Timeframe: Baseline and Week 12.
The change between Body Weight measured at week 20 and Body Weight measured at baseline. (NCT00286468)
Timeframe: Baseline and Week 20.
The change between Body Weight measured at week 26 or final visit and Body Weight measured at baseline. (NCT00286468)
Timeframe: Baseline and Week 26.
The change between Body Weight measured at week 8 and Body Weight measured at baseline. (NCT00286468)
Timeframe: Baseline and Week 8.
The change between the value of C-peptide collected at week 12 and C-peptide collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 12.
The change between the value of C-peptide collected at week 16 and C-peptide collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 16.
The change between the value of C-peptide collected at week 20 and C-peptide collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 20.
The change between the value of C-peptide collected at week 26 or final visit and C-peptide collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 26.
The change between the value of C-peptide collected at week 4 and C-peptide collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 4.
The change between the value of C-peptide collected at week 8 and C-peptide collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 8.
The change between the value of fasting plasma glucose collected at final visit or week 1 and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 1.
The change between the value of fasting plasma glucose collected at week 12 and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 12.
The change between the value of fasting plasma glucose collected at week 16 and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 16.
The change between the value of fasting plasma glucose collected at week 2 and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 2.
The change between the value of fasting plasma glucose collected at week 20 and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 20.
The change between the value of fasting plasma glucose collected at week 26 or final visit and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 26.
The change between the value of fasting plasma glucose collected at week 4 and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 4.
The change between the value of fasting plasma glucose collected at week 8 and fasting plasma glucose collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 8.
The change between the value of fasting proinsulin collected at week 12 and fasting proinsulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 12.
The change between the value of fasting proinsulin collected at week 16 and fasting proinsulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 16.
The change between the value of fasting proinsulin collected at week 20 and fasting proinsulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 20.
The change between the value of fasting proinsulin collected at week 26 or final visit and fasting proinsulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 26.
The change between the value of fasting proinsulin collected at week 4 and fasting proinsulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 4.
The change between the value of fasting proinsulin collected at week 8 and fasting proinsulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 8.
The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 26 or final visit and glycosylated hemoglobin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 26.
The change in the value of Glycosylated Hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 12 and Glycosylated Hemoglobin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 12.
The change in the value of Glycosylated Hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 16 and Glycosylated Hemoglobin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 16.
The change in the value of Glycosylated Hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 20 and Glycosylated Hemoglobin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 20.
The change in the value of Glycosylated Hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 4 and Glycosylated Hemoglobin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 4.
The change in the value of Glycosylated Hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 8 and Glycosylated Hemoglobin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 8.
The change between the value of insulin collected at week 12 and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 12.
The change between the value of insulin collected at week 16 and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 16.
The change between the value of insulin collected at week 20 and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 20.
The change between the value of insulin collected at week 26 and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 26.
The change between the value of insulin collected at week 4 and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 4.
The change between the value of insulin collected at week 8 and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 8.
The change between the ratio value of proinsulin and insulin collected at week 12 and the ratio value of proinsulin and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 12.
The change between the ratio value of proinsulin and insulin collected at week 16 and the ratio value of proinsulin and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 16.
The change between the ratio value of proinsulin and insulin collected at week 20 and the ratio value of proinsulin and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 20.
The change between the ratio value of proinsulin and insulin collected at week 26 or final visit and the ratio value of proinsulin and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 26.
The change between the ratio value of proinsulin and insulin collected at week 4 and the ratio value of proinsulin and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 4.
The change between the ratio value of proinsulin and insulin collected at week 8 and the ratio value of proinsulin and insulin collected at baseline. (NCT00286468)
Timeframe: Baseline and Week 8.
The number of participants requiring rescue for failing to achieve pre-specified glycemic targets during the 26 week study. (NCT00286468)
Timeframe: 26 Weeks.
The number of participants with a value for the percentage of glycosylated hemoglobin (the percentage of hemoglobin that is bound to glucose) less than or equal to 6.5% during the 26 week study. (NCT00286468)
Timeframe: Baseline and Week 26.
The number of participants with a value for the percentage of glycosylated hemoglobin (the percentage of hemoglobin that is bound to glucose) less than or equal to 7.0% during the 26 week study. (NCT00286468)
Timeframe: Baseline and Week 26.
The number of participants with a value for the percentage of glycosylated hemoglobin (the percentage of hemoglobin that is bound to glucose) less than or equal to 7.5% during the 26 week study. (NCT00286468)
Timeframe: Baseline and Week 26.
The number of participants with a decrease from baseline in the percentage of glycosylated hemoglobin (the percentage of hemoglobin that is bound to glucose) greater than or equal to 0.5% during the 26 week study. (NCT00286468)
Timeframe: Baseline and Week 26.
The number of participants with a decrease from baseline in the percentage of glycosylated hemoglobin (the percentage of hemoglobin that is bound to glucose) greater than or equal to 1.0% during the 26 week study. (NCT00286468)
Timeframe: Baseline and Week 26.
The number of participants with a decrease from baseline in the percentage of glycosylated hemoglobin (the percentage of hemoglobin that is bound to glucose) greater than or equal to 1.5% during the 26 week study. (NCT00286468)
Timeframe: Baseline and Week 26.
The number of participants with a decrease from baseline in the percentage of glycosylated hemoglobin (the percentage of hemoglobin that is bound to glucose) greater than or equal to 2.0% during the 26 week study. (NCT00286468)
Timeframe: Baseline and Week 26.
The number of participants with a fasting plasma glucose value greater than or equal to 200 mg per dL during the 26 week study. (NCT00286468)
Timeframe: 26 Weeks.
Disposition index was measured by multiplying the insulin secretion (C-peptide AUC/C-peptide AUC glucose) by the Matsuda index. Disposition index reflects the beta-cell function adjusted for total body insulin sensitivity (NCT00232583)
Timeframe: 72 months
C-peptide-based Matsuda index using following formula: Matsuda index = 500,00 / root square [(fasting c-peptide x fasting glucose x 333) x (average c-peptide 0-120 mins x average glucose 0-120 mins x 333). Higher the Matsuda index, better the insulin sensitivity. (NCT00232583)
Timeframe: 72 months
Current health perception was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 = much better than 3 months ago; 2 - Somewhat better now than 3 months ago; 3 - About the same; 4 - Somewhat worse now than 3 months ago; 5 Much worse now than 3 months ago. (NCT00232583)
Timeframe: 72 months
Glycemia control perception was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a scale score of 1-7, where 1 - extremely controlled and 7 - not at all controlled. (NCT00232583)
Timeframe: 72 months
Hypoglycemia fear was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 - never worry; 2 - rarely water; 3 - sometimes worry; 4 - often worry; 5 - very often worry (NCT00232583)
Timeframe: 72 months
Lifestyle flexibility was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1 to 5, where 1 - a great deal of choice; 2 - a lot of choice; 3 - some choice; 4 - a little choice; 5 - no choice. (NCT00232583)
Timeframe: 72 months
Satisfaction with insulin treatment was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a scale score of 1 to 7, where 1 extremely satisfied to 7 - not at all satisfied. (NCT00232583)
Timeframe: 72 months
Social or vocational worry was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 0-5, where 0 - does not apply; 1 - never; 2 - seldom; 3 - sometimes; 4 - often; 5 - all of the time. (NCT00232583)
Timeframe: 72 months
Social stigma was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1 to 5, where 1- strongly agree; 2 - somewhat agree; 3 - neither agree nor disagree; 4 - somewhat disagree; 5 - strongly disagree. (NCT00232583)
Timeframe: 72 months
Treatment impact was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 - very satisfied; 2 - moderately satisfied; 3 - neither satisfied nor dissatisfied; 4 - moderately dissatisfied; 5 - very dissatisfied. (NCT00232583)
Timeframe: 72 months
Treatment satisfaction was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a Likert scale score of 1-5, where 1 - very satisfied; 2 - moderately satisfied; 3 - neither satisfied nor dissatisfied; 4 - moderately dissatisfied; 5 - very dissatisfied. (NCT00232583)
Timeframe: 72 months
Willingness to continue insulin treatment was measured at randomization and 72 months later using the modified Diabetes Quality of Life Clinical Trial Questionnaire. This questionnaire addresses several areas with respect to diabetes QoL. Answers are in the form of a scale score of 1 to 7, where 1 extremely willing to 7 - not at all willing. (NCT00232583)
Timeframe: 72 months
Plasma glucose (PG) profile measured after 24 weeks of treatment. The time points during the day were: Before breakfast, 120 minutes after start of breakfast, before lunch, 120 minutes after start of lunch, before dinner, 120 minutes after start of dinner, and at bedtime. (NCT00393718)
Timeframe: after 24 weeks of treatment
Mean plasma glucose(PG) in 7-point plasma glucose profile measured after 52 weeks of treatment. The 7 time points during the day were: Before breakfast, 120 minutes after start of breakfast, before lunch, 120 minutes after start of lunch, before dinner, 120 minutes after start of dinner, and at bedtime. (NCT00393718)
Timeframe: after 52 weeks of treatment
Mean postprandial plasma glucose (PG) increment in 7-point plasma glucose profile, ie the mean of the difference of plasma glucose measured before and after a meal, after 24 weeks of treatment. The 7 time points during the day were: Before breakfast, 120 minutes after start of breakfast, before lunch, 120 minutes after start of lunch, before dinner, 120 minutes after start of dinner, and at bedtime. (NCT00393718)
Timeframe: after 24 weeks of treatment
Mean postprandial plasma glucose (PG) increment in 7-point plasma glucose profile, ie the mean of the difference of plasma glucose measured before and after a meal, after 52 weeks of treatment. The 7 time points during the day were: Before breakfast, 120 minutes after start of breakfast, before lunch, 120 minutes after start of lunch, before dinner, 120 minutes after start of dinner, and at bedtime. (NCT00393718)
Timeframe: after 52 weeks of treatment
Postprandial glucose AUC measured 0-3 hours after a meal after 24 weeks of treatment (NCT00393718)
Timeframe: after 24 weeks of treatment
Postprandial glucose AUC measured 0-3 hours after a meal after 52 weeks of treatment (NCT00393718)
Timeframe: after 52 weeks of treatment
Hypoglycaemic episodes measured over 52 weeks of treatment. Hypoglycaemic episodes were defined as major, minor, or symptoms only. Major if the subject was unable to treat her/himself. Minor if subject was able to treat her/himself and plasma glucose was below 3.1 mmol/L. Symptoms only if subject was able to treat her/himself and with no plasma glucose measurement or plasma glucose higher than or equal to 3.1 mmol/L. (NCT00393718)
Timeframe: over 52 weeks of treatment
Number of participants positive for T cell reactivity to islet proteins at 36 months. (NCT00194896)
Timeframe: 36 months
Changes in beta cell function assessed by fasting and stimulated C-peptide measured at 36 months. (NCT00194896)
Timeframe: 36 months
The change in the coefficient of variation (CV) of continuous glucose readings, as assessed by Continuous Glucose Monitoring (CGM) (NCT01524705)
Timeframe: At baseline, 6 months of intervention
Severe hypoglycemia-documented glucose <50mg/dl (participant journal), and hypoglycemic attacks requiring hospitalization, or treatment by emergency personnel. (NCT01524705)
Timeframe: 26 weeks
Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin. (NCT01589445)
Timeframe: 3 months for each drug
Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin. (NCT01589445)
Timeframe: 3 months for each drug
Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin. (NCT01589445)
Timeframe: 3 months for each drug
"Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin.~Analysis 1: Homeostatic Model Assessment of Beta cell function(HOMA percent B) Analysis 2: Homeostatic Model Assessment of Insulin Sensitivity (Homa percent S)" (NCT01589445)
Timeframe: 3 months for each drug
"Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin.~Analysis 1: Homeostasis Model Assessment Insulin Resistance(HOMA IR) Analysis 2: Quantitative Insulin sensitivity Check Index(QUICKI)" (NCT01589445)
Timeframe: 3 months for each drug
"Response rate was defined by ≥10% decrease of FSG or/and ≥1% decrease of HbA1c from the baseline values after 3 months treatment.48 responded to pioglitazone and 32 responded to metformin.~Analysis 1:Total Cholesterol(TC) Analysis 2:Triglyceride(TG) Analysis 3:High Density Lipoprotein(HDL) Analysis 4:Low Density Lipoprotein(LDL)" (NCT01589445)
Timeframe: 3 months for each drug
To determine the intra-tumor concentrations of metformin, with a standard deviation ≤25% of the mean, in patients with solid tumors of thoracic origin administered metformin extended release. (NCT03477162)
Timeframe: Within 7 days from surgery
A measure of the change in fasting plasma glucagon from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks
Change in blood glucose level measured over a 3 month period from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks
All subjects received a Double-Tracer Oral Glucose Tolerance Test (OGTT) with 75g of glucose containing 14C-glucose together with intravenous primed-continuous infusion of 3(3H)-glucose for 240 minutes, at baseline (prior to) and after 16 weeks of therapy. Blood and urine samples were obtained during the OGTT to determine EGP. (NCT02613897)
Timeframe: Baseline and 16 weeks
Number of participants taking Angiotensin-converting enzyme (ACE Inhibitor) or Angiotensin-receptor blocker (ARB) at 12 months (NCT00432809)
Timeframe: 1 year
Change in glycated hemoglobin(HbA1c)from baseline in percentage points / percent change (NCT00432809)
Timeframe: 1 year - baseline
Median percent change in high-sensitivity C-reactive protein (hs-CRP)from baseline at 12 months (NCT00432809)
Timeframe: 1 year
Mean glycated hemoglobin (HbA1c) at 12 months for each of the 3 groups, in percentage points (NCT00432809)
Timeframe: 1 year
The proportion of subjects with a glycated hemoglobin level of 6% or less(without diabetes medications) 12 months after randomization. (NCT00432809)
Timeframe: 1 year
The proportion of subjects with a glycated hemoglobin level of 6% or less(with or without diabetes medications) 12 months after randomization (baseline measure). (NCT00432809)
Timeframe: 1 year
The reported percent change is the difference between TG levels obtained on initial visit (day 0) and TG levels obtained at final visit (week 12) as per protocol (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)
The reported percent change is the difference between HDL levels obtained on initial visit (day 0) and HDL levels obtained at final visit (week 12) as per protocol (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)
The reported percent change is the difference between LDL levels obtained on initial visit (day 0) and LDL levels obtained at final visit (week 12) as per protocol (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)
The mean Levels of AST and ALT measured at initial visit (Day 0) and final visit (Week 12) annotated as AST 1, AST 12, and ALT 1 and ALT 12, respectively. (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)
Post-treatment median change in Apo AI, Apo AII and Apo CIII levels reported in mg/dL with Interquartile ranges provided (NCT00819910)
Timeframe: 12 weeks from initial visit (day 0) to final visit (12 weeks)
"We will examine the effect of HCQ on HOMA-IR during the active treatment phase compared with placebo phase.~HOMA-IR = (Glucose x insulin)/405" (NCT01132118)
Timeframe: Baseline and Week 8
"We will examine the effect of HCQ on the Matsuda Insulin Sensitivity Index (ISI) during the active treatment phase compared with placebo phase.~ISI is based on insulin and glucose levels in a fasting state during an oral glucose tolerance test (OGTT) and is calculated as follows:~ISI (Matsuda) = 10000/√ G0 X I0 X Gmean X Imean~G0 - fasting plasma glucose (mg/dL) I0 - fasting plasma insulin (mIU/L) Gmean - mean plasma glucose during OGTT (mg/dL) Imean - mean plasma insulin during OGTT (mIU/L)" (NCT01132118)
Timeframe: Baseline and Week 8
| Article | Year |
|---|
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial.Diabetes & metabolism, 2021, Volume: 47, Issue:6
Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Glucosides; Glyburide; Glycated Hemo | 2021 |
Pharmacokinetic and Bioequivalence Studies of 2 Metformin Glibenclamide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions.Clinical pharmacology in drug development, 2023, Volume: 12, Issue:5
Topics: Cross-Over Studies; Diabetes Mellitus, Type 2; East Asian People; Fasting; Glyburide; Humans; Metfor | 2023 |
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.Cardiovascular diabetology, 2021, 03-26, Volume: 20, Issue:1
Topics: Adult; Aged; Benzhydryl Compounds; Biomarkers; Blood Glucose; Brazil; Carotid Artery Diseases; Diabe | 2021 |
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.Nutrition & diabetes, 2021, 06-12, Volume: 11, Issue:1
Topics: Absorptiometry, Photon; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Body Composition; Body Wei | 2021 |
Influence of the SLCO1B3 Gene on Sulfonylurea Failure in Patients with Type 2 Diabetes in China.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2017, Volume: 125, Issue:7
Topics: Aged; Amino Acid Substitution; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Genotype; Glybu | 2017 |
Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitus.Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:9
Topics: Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase | 2018 |
Impact of treatment with glibenclamide or vildagliptin on glucose variability after aerobic exercise in type 2 diabetes: A randomized controlled trial.Diabetes research and clinical practice, 2018, Volume: 143Topics: Adamantane; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exercise; Female; G | 2018 |
Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial.Acta diabetologica, 2018, Volume: 55, Issue:12
Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Endot | 2018 |
A randomized controlled clinical trial evaluating the effect of African health sciences, 2019, Volume: 19, Issue:1
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gly | 2019 |
The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes.Endocrine journal, 2019, Oct-28, Volume: 66, Issue:10
Topics: Adiponectin; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agent | 2019 |
A comparison between sitagliptin or glibenclamide in addition to metformin + pioglitazone on glycaemic control and β-cell function: the triple oral therapy.Diabetic medicine : a journal of the British Diabetic Association, 2013, Volume: 30, Issue:7
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; F | 2013 |
A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year study.Diabetes technology & therapeutics, 2013, Volume: 15, Issue:3
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; F | 2013 |
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.European journal of gastroenterology & hepatology, 2013, Volume: 25, Issue:9
Topics: Adipokines; Aged; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2 | 2013 |
Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus.Clinical interventions in aging, 2013, Volume: 8Topics: Adamantane; Aged; Aged, 80 and over; Analysis of Variance; Area Under Curve; Diabetes Mellitus, Type | 2013 |
Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials.Postgraduate medicine, 2013, Volume: 125, Issue:3
Topics: Adamantane; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV | 2013 |
Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus.Clinical science (London, England : 1979), 2014, Volume: 126, Issue:2
Topics: Adult; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; H | 2014 |
An open-label drug-drug interaction study of the steady-state pharmacokinetics of topiramate and glyburide in patients with type 2 diabetes mellitus.Clinical drug investigation, 2013, Volume: 33, Issue:12
Topics: Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Drug Interactions; Female; Fructose; Glyburide; | 2013 |
Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China.Diabetologia, 2014, Volume: 57, Issue:4
Topics: China; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Diabetes Mellit | 2014 |
Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial.Journal of ethnopharmacology, 2014, Mar-28, Volume: 152, Issue:3
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glyca | 2014 |
Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus.Phytotherapy research : PTR, 2014, Volume: 28, Issue:12
Topics: Adult; Blood Glucose; Capsules; Curcumin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyb | 2014 |
The effect of glibenclamide on insulin secretion at normal glucose concentrations.Diabetologia, 2015, Volume: 58, Issue:1
Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glu | 2015 |
Effects of vildagliptin compared with glibenclamide on glucose variability after a submaximal exercise test in patients with type 2 diabetes: study protocol for a randomized controlled trial, DIABEX VILDA.Trials, 2014, Nov-04, Volume: 15Topics: Adamantane; Biomarkers; Blood Glucose; Brazil; Clinical Protocols; Diabetes Mellitus, Type 2; Dipept | 2014 |
Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.Nutrition journal, 2015, Jan-26, Volume: 14Topics: Adult; Aged; Atherosclerosis; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind | 2015 |
Glycemic excursions are positively associated with changes in duration of asymptomatic hypoglycemia after treatment intensification in patients with type 2 diabetes.Diabetes research and clinical practice, 2016, Volume: 113Topics: Acarbose; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; | 2016 |
Combined Influence of Genetic Variants and Gene-gene Interaction on Sulfonylurea Efficacy in Type 2 Diabetic Patients.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2016, Volume: 124, Issue:3
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Epistasis, Genetic; Female; Genetic Variation; Glyburide; Hu | 2016 |
Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy.Journal of diabetes, 2017, Volume: 9, Issue:3
Topics: Acarbose; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glybur | 2017 |
A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids.The American journal of medicine, 2016, Volume: 129, Issue:7
Topics: Adult; Anticholesteremic Agents; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitu | 2016 |
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial.Diabetes care, 2016, Volume: 39, Issue:8
Topics: Adamantane; Aged; Body Mass Index; Diabetes Mellitus, Type 2; Dipeptides; Female; Follow-Up Studies; | 2016 |
Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Piragliatin, a Glucokinase Activator, and Glyburide, a Sulfonylurea, in Type 2 Diabetic Patients.Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6
Topics: Adult; Aged; Benzeneacetamides; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double | 2016 |
Genetic and Clinical Predictive Factors of Sulfonylurea Failure in Patients with Type 2 Diabetes.Diabetes technology & therapeutics, 2016, Volume: 18, Issue:9
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucuronosyltransferase | 2016 |
Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism.Journal of clinical pharmacology, 2017, Volume: 57, Issue:6
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Area Under Curve; Carba | 2017 |
Factors of primary and secondary sulfonylurea failure in type 2 diabetic subjects.Journal of diabetes, 2017, Volume: 9, Issue:12
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glyburide; Glycated | 2017 |
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes.International journal of clinical pharmacology and therapeutics, 2008, Volume: 46, Issue:7
Topics: Adamantane; Adult; Aged; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Typ | 2008 |
Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.Geriatrics & gerontology international, 2008, Volume: 8, Issue:3
Topics: Aged; Aged, 80 and over; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Administra | 2008 |
Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.Acta diabetologica, 2009, Volume: 46, Issue:1
Topics: Administration, Oral; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gl | 2009 |
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:2
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; D | 2009 |
Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:1
Topics: Blood Glucose; Body Mass Index; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Drug T | 2009 |
Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.Clinical pharmacology and therapeutics, 2009, Volume: 85, Issue:6
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Cytochrome P-450 CYP2C9; Diab | 2009 |
Effect of two starting insulin regimens in patients with type II diabetes not controlled on a combination of oral antihyperglycemic medications.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, Volume: 117, Issue:5
Topics: Animals; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administrat | 2009 |
Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus.Metabolism: clinical and experimental, 2009, Volume: 58, Issue:7
Topics: Adiponectin; Adult; Blood Glucose; C-Reactive Protein; Cohort Studies; Coronary Vessels; Diabetes Me | 2009 |
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?Diabetes care, 2009, Volume: 32, Issue:10
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemi | 2009 |
Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US.Drug safety, 2009, Volume: 32, Issue:9
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Chemical and Drug Induced Liver Injury; D | 2009 |
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).Diabetes care, 2010, Volume: 33, Issue:1
Topics: Adult; Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic | 2010 |
Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:1
Topics: Adult; Aged; Biomarkers; Bone and Bones; Bone Resorption; Diabetes Mellitus, Type 2; Double-Blind Me | 2010 |
Exenatide versus glibenclamide in patients with diabetes.Diabetes technology & therapeutics, 2010, Volume: 12, Issue:3
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Body Weight; C-Reactive | 2010 |
Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes.Current medical research and opinion, 2010, Volume: 26, Issue:5
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Sche | 2010 |
Coadministration of muraglitazar plus glyburide: improvement of glycaemic and lipid profiles in patients with type 2 diabetes.Diabetes & vascular disease research, 2009, Volume: 6, Issue:2
Topics: Administration, Oral; Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therap | 2009 |
[Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].Terapevticheskii arkhiv, 2010, Volume: 82, Issue:8
Topics: Blood Glucose; Carbohydrate Metabolism; Combined Modality Therapy; Diabetes Mellitus, Type 2; Eating | 2010 |
Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients.International journal of clinical practice, 2010, Volume: 64, Issue:13
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Ankle; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Angiop | 2010 |
Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects.Drug metabolism and pharmacokinetics, 2011, Volume: 26, Issue:2
Topics: Adolescent; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Cross-O | 2011 |
Sesame oil exhibits synergistic effect with anti-diabetic medication in patients with type 2 diabetes mellitus.Clinical nutrition (Edinburgh, Scotland), 2011, Volume: 30, Issue:3
Topics: Antioxidants; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Food-Drug | 2011 |
Effect of repaglinide versus glyburide on postprandial glucose and insulin values in elderly patients with type 2 diabetes.Diabetes technology & therapeutics, 2011, Volume: 13, Issue:1
Topics: Aged; Area Under Curve; Blood Glucose; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Fe | 2011 |
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia.Diabetic medicine : a journal of the British Diabetic Association, 2011, Volume: 28, Issue:5
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Di | 2011 |
Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects.Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:7
Topics: Adamantane; Adolescent; Adult; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl | 2011 |
Effects of insulin versus sulphonylurea on beta-cell secretion in recently diagnosed type 2 diabetes patients: a 6-year follow-up study.The review of diabetic studies : RDS, 2010,Fall, Volume: 7, Issue:3
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucagon; Glyburide; H | 2010 |
Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.Diabetes, 2011, Volume: 60, Issue:5
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin Resistance; | 2011 |
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.Clinical journal of the American Society of Nephrology : CJASN, 2011, Volume: 6, Issue:5
Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diab | 2011 |
Safety and efficacy of saxagliptin in combination with submaximal sulphonylurea versus up-titrated sulphonylurea over 76 weeks.Diabetes & vascular disease research, 2011, Volume: 8, Issue:2
Topics: Adamantane; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Pepti | 2011 |
Pioglitazone compared to glibenclamide on lipid profile and inflammation markers in type 2 diabetic patients during an oral fat load.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2011, Volume: 43, Issue:7
Topics: Administration, Oral; Biomarkers; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Female; G | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.Postgraduate medicine, 2011, Volume: 123, Issue:4
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidy | 2011 |
Comparison of antihyperglycemic effects of creatine and glibenclamide in type II diabetic patients.Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:21-22
Topics: Adult; Blood Glucose; C-Peptide; Creatine; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gl | 2011 |
Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.Diabetes research and clinical practice, 2011, Volume: 94, Issue:2
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; | 2011 |
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.Clinical therapeutics, 2011, Volume: 33, Issue:12
Topics: Acarbose; Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dinoprost; | 2011 |
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.Clinical therapeutics, 2011, Volume: 33, Issue:12
Topics: Acarbose; Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dinoprost; | 2011 |
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.Clinical therapeutics, 2011, Volume: 33, Issue:12
Topics: Acarbose; Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dinoprost; | 2011 |
Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.Clinical therapeutics, 2011, Volume: 33, Issue:12
Topics: Acarbose; Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dinoprost; | 2011 |
Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial.Planta medica, 2012, Volume: 78, Issue:4
Topics: Adult; Aloe; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gels; Glyburide; Humans; Hyperc | 2012 |
The effect of sitagliptin versus glibenclamide on arterial stiffness, blood pressure, lipids, and inflammation in type 2 diabetes mellitus patients.Diabetes technology & therapeutics, 2012, Volume: 14, Issue:7
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; C-Reactive Protein; Cross-Over Studies; Diab | 2012 |
β-cell function preservation after 3.5 years of intensive diabetes therapy.Diabetes care, 2012, Volume: 35, Issue:7
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Human | 2012 |
Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes.Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2012, Volume: 60, Issue:7
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Disease Progression; Fatty Liver; Fema | 2012 |
Lack of the QTc physiologic decrease during cardiac stress test in patients with type 2 diabetes treated with secretagogues.Acta diabetologica, 2014, Volume: 51, Issue:1
Topics: Aged; Arrhythmias, Cardiac; Carbamates; Diabetes Mellitus, Type 2; Electrocardiography; Exercise Tes | 2014 |
The R230C variant of the ATP binding cassette protein A1 (ABCA1) gene is associated with a decreased response to glyburide therapy in patients with type 2 diabetes mellitus.Metabolism: clinical and experimental, 2013, Volume: 62, Issue:5
Topics: Adult; Aged; Amino Acid Substitution; Arginine; ATP Binding Cassette Transporter 1; ATP-Binding Cass | 2013 |
Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.Clinical and experimental immunology, 2013, Volume: 171, Issue:2
Topics: Adult; Aged; Autoantibodies; Autoimmunity; C-Peptide; Cells, Cultured; Diabetes Mellitus, Type 2; Di | 2013 |
Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes.Metabolism: clinical and experimental, 2013, Volume: 62, Issue:5
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Down-Regulation; Exercise; Female; Glucose Clamp Technique; | 2013 |
Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.Diabetes care, 2002, Volume: 25, Issue:8
Topics: Aged; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Female | 2002 |
Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:8
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blin | 2002 |
Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting.Diabetes research and clinical practice, 2002, Volume: 58, Issue:1
Topics: Biomarkers; Carbamates; Diabetes Mellitus, Type 2; Fasting; Feeding Behavior; Female; Fructosamine; | 2002 |
The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.Diabetes, nutrition & metabolism, 2002, Volume: 15, Issue:3
Topics: Acarbose; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Ther | 2002 |
Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.The Journal of the Association of Physicians of India, 2002, Volume: 50, Issue:5
Topics: Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therap | 2002 |
Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:9
Topics: Adult; Aged; Antioxidants; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Free Radicals; Glicl | 2002 |
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.Diabetes care, 2002, Volume: 25, Issue:10
Topics: Albuminuria; Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Gly | 2002 |
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes.Diabetes care, 2002, Volume: 25, Issue:11
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Physiological Phenomena; | 2002 |
Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy.Diabetes, obesity & metabolism, 2002, Volume: 4, Issue:6
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Femal | 2002 |
Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect.The American journal of cardiology, 2002, Nov-15, Volume: 90, Issue:10
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Diabetes Mellitus, Type 2; Electrocardiogra | 2002 |
Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.Proceedings of the Western Pharmacology Society, 2002, Volume: 45Topics: Adult; Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Drug Combinations; | 2002 |
Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.Proceedings of the Western Pharmacology Society, 2002, Volume: 45Topics: Adult; Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Drug Combinations; | 2002 |
Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.Clinical pharmacokinetics, 2002, Volume: 41, Issue:15
Topics: Adult; Aged; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double- | 2002 |
Combination therapy of alpha-glucosidase inhibitor and a sulfonylurea compound prolongs the duration of good glycemic control.Metabolism: clinical and experimental, 2002, Volume: 51, Issue:12
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glic | 2002 |
Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients.Diabetes, obesity & metabolism, 2003, Volume: 5, Issue:1
Topics: Acarbose; Adult; Aged; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Doubl | 2003 |
Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus.The American journal of the medical sciences, 2003, Volume: 325, Issue:2
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Glyburide; Hemoglobin A; Humans; Hypogl | 2003 |
Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy.Diabetes, 2003, Volume: 52, Issue:3
Topics: Adipocytes; Adiponectin; Adipose Tissue; Adult; Aged; Biopsy; Chromans; Culture Media, Conditioned; | 2003 |
Leptin and body fat in type 2 diabetes and monodrug therapy.The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:4
Topics: Adipose Tissue; Body Composition; Body Mass Index; Cholesterol, HDL; Cross-Over Studies; Diabetes Me | 2003 |
Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.Autoimmunity, 2002, Volume: 35, Issue:7
Topics: Autoantibodies; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Melli | 2002 |
Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.Metabolism: clinical and experimental, 2003, Volume: 52, Issue:4
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Epi | 2003 |
Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome.Endocrine, 2003, Volume: 20, Issue:3
Topics: Blood Glucose; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glyburide; Hu | 2003 |
Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C.Diabetes technology & therapeutics, 2003, Volume: 5, Issue:1
Topics: Adult; Asian People; Blood Glucose; China; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Ther | 2003 |
Metabolic effects of mealtime insulin lispro in comparison to glibenclamide in early type 2 diabetes.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2003, Volume: 111, Issue:2
Topics: Age of Onset; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Eating; Fema | 2003 |
Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control.Journal of endocrinological investigation, 2003, Volume: 26, Issue:3
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Therapy, Combination | 2003 |
Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study.Metabolism: clinical and experimental, 2003, Volume: 52, Issue:7
Topics: Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Bli | 2003 |
Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.Diabetes care, 2003, Volume: 26, Issue:8
Topics: Adult; Aged; Amyloid; Blood Glucose; Body Weight; C-Peptide; Cholesterol, HDL; Diabetes Mellitus, Ty | 2003 |
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combin | 2003 |
Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study.Diabetologia, 2003, Volume: 46, Issue:12
Topics: Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cohort Studies; Diabetes Mellitus, Type 2; | 2003 |
Comparative bioavailability of two oral formulations manufactured in Mexico containing glyburide and metformin in diabetic patients.Proceedings of the Western Pharmacology Society, 2003, Volume: 46Topics: Aged; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pre | 2003 |
A placebo-controlled crossover study comparing the effects of nateglinide and glibenclamide on postprandial hyperglycaemia and hyperinsulinaemia in patients with type 2 diabetes.Diabetes, obesity & metabolism, 2004, Volume: 6, Issue:2
Topics: Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Double- | 2004 |
Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.Clinical therapeutics, 2003, Volume: 25, Issue:12
Topics: Adult; Aged; Biphasic Insulins; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; | 2003 |
Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus.Diabetes research and clinical practice, 2004, Volume: 63, Issue:3
Topics: Adult; Aged; Aged, 80 and over; C-Peptide; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Ty | 2004 |
Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial.The American journal of medicine, 2004, Feb-15, Volume: 116, Issue:4
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glyb | 2004 |
Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.Diabetes technology & therapeutics, 2004, Volume: 6, Issue:1
Topics: Administration, Oral; Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, | 2004 |
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.Circulation, 2004, Jul-13, Volume: 110, Issue:2
Topics: Adult; Aged; Biomarkers; Blood Glucose; Carbamates; Carotid Artery Diseases; Cross-Sectional Studies | 2004 |
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.Circulation, 2004, Jul-13, Volume: 110, Issue:2
Topics: Adult; Aged; Biomarkers; Blood Glucose; Carbamates; Carotid Artery Diseases; Cross-Sectional Studies | 2004 |
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.Circulation, 2004, Jul-13, Volume: 110, Issue:2
Topics: Adult; Aged; Biomarkers; Blood Glucose; Carbamates; Carotid Artery Diseases; Cross-Sectional Studies | 2004 |
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.Circulation, 2004, Jul-13, Volume: 110, Issue:2
Topics: Adult; Aged; Biomarkers; Blood Glucose; Carbamates; Carotid Artery Diseases; Cross-Sectional Studies | 2004 |
Does bromocriptine improve glycemic control of obese type-2 diabetics?Hormone research, 2004, Volume: 62, Issue:2
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agon | 2004 |
Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity.Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:2
Topics: Administration, Oral; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; | 2004 |
Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:8
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin Re | 2004 |
Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.Metabolism: clinical and experimental, 2004, Volume: 53, Issue:10
Topics: Adult; Aged; Area Under Curve; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind | 2004 |
Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.Romanian journal of internal medicine = Revue roumaine de medecine interne, 2003, Volume: 41, Issue:2
Topics: Administration, Oral; Adult; Biphasic Insulins; Blood Glucose; Diabetes Mellitus, Type 2; Drug Admin | 2003 |
Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.International journal of clinical practice, 2004, Volume: 58, Issue:9
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide | 2004 |
Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.Clinical therapeutics, 2004, Volume: 26, Issue:9
Topics: Adult; Aged; Appetite Depressants; Blood Glucose; Cyclobutanes; Diabetes Mellitus, Type 2; Double-Bl | 2004 |
Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.Metabolism: clinical and experimental, 2004, Volume: 53, Issue:11
Topics: Adiponectin; Blood Glucose; Body Composition; C-Reactive Protein; Cross-Over Studies; Diabetes Melli | 2004 |
Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.Diabetologia, 2004, Volume: 47, Issue:11
Topics: Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fem | 2004 |
Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes.The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:12
Topics: Aged; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glyb | 2004 |
Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.Clinical physiology and functional imaging, 2005, Volume: 25, Issue:1
Topics: Adult; Analysis of Variance; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationsh | 2005 |
Repaglinide administration improves brachial reactivity in type 2 diabetic patients.Diabetes care, 2005, Volume: 28, Issue:2
Topics: Aged; Blood Glucose; Brachial Artery; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Dia | 2005 |
Effect of pioglitazone on arteriosclerosis in comparison with that of glibenclamide.Diabetes research and clinical practice, 2005, Volume: 68, Issue:2
Topics: Arteriosclerosis; Blood Glucose; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Administration Sc | 2005 |
Effects of two different glibenclamide dose-strengths in the fixed combination with metformin in patients with poorly controlled T2DM: a double blind, prospective, randomised, cross-over clinical trial.Diabetes, nutrition & metabolism, 2004, Volume: 17, Issue:6
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Dou | 2004 |
Efficacy of glimepiride in Japanese type 2 diabetic subjects.Diabetes research and clinical practice, 2005, Volume: 68, Issue:3
Topics: Aged; Asian People; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fe | 2005 |
Secondary sulfonylurea failure: comparison of period until insulin treatment between diabetic patients treated with gliclazide and glibenclamide.Diabetes research and clinical practice, 2005, Volume: 70, Issue:3
Topics: Age of Onset; Databases, Factual; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glic | 2005 |
Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance.Diabetes & metabolism, 2005, Volume: 31, Issue:2
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule | 2005 |
PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin.Diabetes care, 2005, Volume: 28, Issue:9
Topics: Body Mass Index; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy | 2005 |
The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:6
Topics: Adult; Aged; Anthropometry; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; | 2005 |
Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.Clinical therapeutics, 2005, Volume: 27, Issue:9
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hem | 2005 |
Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005, Dec-06, Volume: 173, Issue:12
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dyslipidemi | 2005 |
The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:12
Topics: Aged; Aged, 80 and over; Biphasic Insulins; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; D | 2005 |
Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study.Clinical therapeutics, 2005, Volume: 27, Issue:10
Topics: Adult; Alzheimer Disease; Diabetes Mellitus, Type 2; Drug Combinations; Drug Interactions; Female; G | 2005 |
Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:1
Topics: Biphasic Insulins; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedu | 2006 |
Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:2
Topics: Adenosine Diphosphate; Blood Glucose; C-Reactive Protein; Carbamates; Cross-Over Studies; Diabetes M | 2006 |
Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes care, 2006, Volume: 29, Issue:2
Topics: Adult; Aged; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 2006 |
Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy.Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:2
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combin | 2006 |
Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis.The journal of medical investigation : JMI, 2006, Volume: 53, Issue:1-2
Topics: Adipocytes; Aged; Atherosclerosis; Cytokines; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; | 2006 |
Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes.Endocrine, 2006, Volume: 29, Issue:1
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nones | 2006 |
Association of gliclazide and left ventricular mass in type 2 diabetic patients.Diabetes research and clinical practice, 2006, Volume: 74, Issue:2
Topics: Aged; Body Mass Index; Diabetes Mellitus, Type 2; Electrocardiography; Female; Gliclazide; Glyburide | 2006 |
Impact of rosiglitazone on glycaemic control, insulin levels and blood pressure values in patients with type 2 diabetes.Medicinski arhiv, 2006, Volume: 60, Issue:3
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; In | 2006 |
Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia.Diabetes & metabolism, 2006, Volume: 32, Issue:3
Topics: Adiponectin; Aged; Blood Glucose; Body Mass Index; Cohort Studies; Cytokines; Diabetes Mellitus, Typ | 2006 |
The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients.The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:9
Topics: Diabetes Mellitus, Type 2; DNA; Edema; Female; Genetic Predisposition to Disease; Genotype; Glyburid | 2006 |
Beta-cell response to metformin-glibenclamide combination tablets (Glucovance) in patients with type 2 diabetes.International journal of clinical practice, 2006, Volume: 60, Issue:7
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blin | 2006 |
Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study.Current medical research and opinion, 2006, Volume: 22, Issue:6
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypo | 2006 |
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.Diabetes care, 2006, Volume: 29, Issue:8
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glybur | 2006 |
Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial.Diabetes care, 2006, Volume: 29, Issue:8
Topics: Aged; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Glyburide; Humans; Piperidines | 2006 |
Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.Journal of internal medicine, 2006, Volume: 260, Issue:2
Topics: Adiponectin; Administration, Oral; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Cystatin C | 2006 |
Nateglinide with glibenclamide examination using the respiratory quotient (RQ).The journal of medical investigation : JMI, 2006, Volume: 53, Issue:3-4
Topics: Aged; Blood Glucose; Body Weight; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Glyburide; Humans | 2006 |
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.Journal of hypertension, 2006, Volume: 24, Issue:10
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Pressure; Cohort Studies; Diabetes Mellitus, Type | 2006 |
Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients.Diabetes & metabolism, 2006, Volume: 32, Issue:4
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; Glycated Hemoglobin; | 2006 |
Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.Pharmacotherapy, 2006, Volume: 26, Issue:10
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Drug-Related Side Effects and | 2006 |
Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers.Clinical and experimental hypertension (New York, N.Y. : 1993), 2006, Volume: 28, Issue:7
Topics: Adolescent; Adult; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Diabetes Mellitus, | 2006 |
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe.Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:12
Topics: Adult; Age Distribution; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Europe; Female; Glyburide; | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; G | 2006 |
A one-year study comparing the efficacy and safety of rosiglitazone and glibenclamide in the treatment of type 2 diabetes.Nutrition, metabolism, and cardiovascular diseases : NMCD, 2007, Volume: 17, Issue:1
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus | 2007 |
Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.Diabetes, obesity & metabolism, 2007, Volume: 9, Issue:1
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Gliclazi | 2007 |
Lowering effect on postprandial glycemic response of nopales added to Mexican breakfasts.Diabetes care, 2007, Volume: 30, Issue:5
Topics: Aged; Blood Glucose; Cactaceae; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Eating; Glybur | 2007 |
[ADOPT study: which first-line glucose-lowering oral medication in type 2 diabetes?].Revue medicale de Liege, 2007, Volume: 62, Issue:1
Topics: Administration, Oral; Belgium; Canada; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Double-Blin | 2007 |
Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up.Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:5
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration S | 2008 |
Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes.Journal of endocrinological investigation, 2007, Volume: 30, Issue:4
Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Doubl | 2007 |
Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes.Diabetologia, 2007, Volume: 50, Issue:9
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind | 2007 |
Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.Clinical therapeutics, 2007, Volume: 29, Issue:5
Topics: Adolescent; Adult; Aged; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gl | 2007 |
'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas.Coronary artery disease, 2007, Volume: 18, Issue:6
Topics: Angina Pectoris; Blood Pressure; Diabetes Mellitus, Type 2; Exercise; Gliclazide; Glyburide; Heart R | 2007 |
Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes.Diabetes technology & therapeutics, 2007, Volume: 9, Issue:4
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated | 2007 |
Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes.Journal of medicinal food, 2007, Volume: 10, Issue:3
Topics: Adult; Antioxidants; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; | 2007 |
The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.Nutrition, metabolism, and cardiovascular diseases : NMCD, 2008, Volume: 18, Issue:5
Topics: Aged; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dru | 2008 |
Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes.Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:8
Topics: Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Cyclohexanes; Diabetes Mellitus, Type 2; Do | 2008 |
Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.Clinical endocrinology, 2008, Volume: 68, Issue:5
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Humans; Hyp | 2008 |
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial.Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:22
Topics: Adult; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fema | 2007 |
A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes Clinical therapeutics, 2007, Volume: 29, Issue:9
Topics: Black or African American; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Resistance; Drug The | 2007 |
Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.Journal of the Chinese Medical Association : JCMA, 2007, Volume: 70, Issue:11
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glyburide; Gly | 2007 |
Increased hematocrit and reduced blood pressure following control of glycemia in diabetes.Clinical hemorheology and microcirculation, 2008, Volume: 38, Issue:1
Topics: Blood Glucose; Blood Pressure; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug | 2008 |
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).Diabetes care, 2008, Volume: 31, Issue:5
Topics: Age of Onset; Aged; Diabetes Mellitus, Type 2; Disease Progression; Female; Fractures, Bone; Glyburi | 2008 |
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).Diabetes care, 2008, Volume: 31, Issue:5
Topics: Age of Onset; Aged; Diabetes Mellitus, Type 2; Disease Progression; Female; Fractures, Bone; Glyburi | 2008 |
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).Diabetes care, 2008, Volume: 31, Issue:5
Topics: Age of Onset; Aged; Diabetes Mellitus, Type 2; Disease Progression; Female; Fractures, Bone; Glyburi | 2008 |
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).Diabetes care, 2008, Volume: 31, Issue:5
Topics: Age of Onset; Aged; Diabetes Mellitus, Type 2; Disease Progression; Female; Fractures, Bone; Glyburi | 2008 |
Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:3
Topics: Blood Glucose; Cardiovascular Physiological Phenomena; Case-Control Studies; Diabetes Mellitus, Type | 2008 |
[Combination therapy with insulin and sulfonylurea in secondary failure of sulfonylurea therapy].Deutsche medizinische Wochenschrift (1946), 1984, Mar-16, Volume: 109, Issue:11
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycat | 1984 |
[Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)].Deutsche medizinische Wochenschrift (1946), 1984, Feb-10, Volume: 109, Issue:6
Topics: Adult; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind M | 1984 |
The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes.Acta endocrinologica, 1984, Volume: 106, Issue:1
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug The | 1984 |
The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?British medical journal (Clinical research ed.), 1984, Jun-30, Volume: 288, Issue:6435
Topics: Adult; Aged; Attitude to Health; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, | 1984 |
Diabetic control with gliquidone--a short acting sulphonylurea.European journal of clinical pharmacology, 1984, Volume: 26, Issue:4
Topics: Adolescent; Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary | 1984 |
Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes.Annals of clinical research, 1983, Volume: 15 Suppl 37Topics: Aged; Chemistry, Pharmaceutical; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Glybur | 1983 |
A double-blind comparison of two glibenclamide preparations, HB 419 and HB 420, in maturity-onset (type 2) diabetic patients.Annals of clinical research, 1983, Volume: 15 Suppl 37Topics: Aged; Chemistry, Pharmaceutical; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind M | 1983 |
Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.Klinische Wochenschrift, 1984, Jul-02, Volume: 62, Issue:13
Topics: Adult; Binding, Competitive; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Do | 1984 |
Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics.European journal of clinical pharmacology, 1984, Volume: 27, Issue:2
Topics: Acarbose; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Glucagon; Glyburide; Humans | 1984 |
Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.The American journal of medicine, 1984, Volume: 77, Issue:6
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combin | 1984 |
Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes.The Tohoku journal of experimental medicine, 1983, Volume: 141 SupplTopics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Retinopath | 1983 |
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.Diabetes care, 1995, Volume: 18, Issue:3
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholestero | 1995 |
Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.Diabete & metabolisme, 1995, Volume: 21, Issue:3
Topics: 1-Deoxynojirimycin; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet, D | 1995 |
Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.Diabetes care, 1995, Volume: 18, Issue:8
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus | 1995 |
Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus.The American journal of cardiology, 1995, Jul-13, Volume: 76, Issue:2
Topics: Administration, Oral; Anticholesteremic Agents; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind | 1995 |
Insulin response after treatment depends on fasting plasma glucose level in NIDDM.Diabetes research and clinical practice, 1994, Dec-16, Volume: 26, Issue:2
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Fasting | 1994 |
The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:2
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Interactions | 1995 |
Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.Diabetes care, 1994, Volume: 17, Issue:10
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Drug | 1994 |
Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients.Acta diabetologica, 1994, Volume: 31, Issue:3
Topics: Adult; Blood Glucose; Blood Pressure; C-Peptide; Chlorpropamide; Cholesterol; Diabetes Mellitus, Typ | 1994 |
United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.BMJ (Clinical research ed.), 1995, Jan-14, Volume: 310, Issue:6972
Topics: Adult; Aged; Blood Glucose; Body Weight; Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type | 1995 |
Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction.Coronary artery disease, 1994, Volume: 5, Issue:9
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Male; Middle A | 1994 |
Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:10
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therap | 1994 |
Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:10
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therap | 1994 |
Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:10
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therap | 1994 |
Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:10
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therap | 1994 |
Glibenclamide vs gliclazide in type 2 diabetes of the elderly.Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:10
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; Humans; Hypoglycemia; | 1994 |
Bedtime dosing of glyburide and the treatment of type II diabetes mellitus.The American journal of the medical sciences, 1994, Volume: 308, Issue:4
Topics: Adolescent; Adult; Aged; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 2; Double-Blind Me | 1994 |
Prolonged response to glibenclamide in NIDDM patients in a normoglycemic state.Israel journal of medical sciences, 1994, Volume: 30, Issue:10
Topics: Adult; Aged; Biological Availability; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Gly | 1994 |
Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM.Diabetes care, 1994, Volume: 17, Issue:9
Topics: Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Exercise; Glyburide; Glycated H | 1994 |
[Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].Medizinische Klinik (Munich, Germany : 1983), 1994, Apr-15, Volume: 89, Issue:4
Topics: Acarbose; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dose- | 1994 |
Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:3
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Fasting; Female; Glucose Tolerance T | 1994 |
A long-term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes.Journal of internal medicine, 1994, Volume: 236, Issue:3
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Glyburide; Glycate | 1994 |
Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.Diabetes care, 1994, Volume: 17, Issue:6
Topics: Acarbose; Adult; Aged; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet | 1994 |
Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.Diabetes care, 1994, Volume: 17, Issue:1
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glipizide; Glyburide; Glycate | 1994 |
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.European journal of clinical pharmacology, 1993, Volume: 45, Issue:2
Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glybur | 1993 |
Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures--a study of patients with non-insulin-dependent diabetes mellitus.Journal of clinical pharmacy and therapeutics, 1993, Volume: 18, Issue:4
Topics: Diabetes Mellitus, Type 2; Drug Prescriptions; Female; Glyburide; Health Services Research; Humans; | 1993 |
Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients.Annals of the New York Academy of Sciences, 1993, Jun-14, Volume: 683Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dietary Fats, Unsatur | 1993 |
Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.Diabetes care, 1993, Volume: 16, Issue:6
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug | 1993 |
Different takes on the relationship of insulin treatment to blood pressure.Diabetes care, 1993, Volume: 16, Issue:6
Topics: Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Gl | 1993 |
Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.Diabetes care, 1993, Volume: 16, Issue:7
Topics: Biomarkers; Blood Glucose; Blood Pressure; Cardiac Output; Cholesterol; Cholesterol, HDL; Cholestero | 1993 |
Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide.BMJ (Clinical research ed.), 1993, Jul-31, Volume: 307, Issue:6899
Topics: Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fasting; Female; Fructosamine; Glyburid | 1993 |
Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus?Scandinavian journal of clinical and laboratory investigation, 1993, Volume: 53, Issue:4
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Glucose; Glyburide; Humans; Insulin; Metabolic Clearance Rat | 1993 |
The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.Journal of clinical pharmacology, 1993, Volume: 33, Issue:3
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Femal | 1993 |
Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.Diabete & metabolisme, 1995, Volume: 21, Issue:6
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fe | 1995 |
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.Lancet (London, England), 1996, Jun-01, Volume: 347, Issue:9014
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Ev | 1996 |
An importance of carbohydrate ingestion for the expression of the effect of alpha-glucosidase inhibitor in NIDDM.Diabetes care, 1996, Volume: 19, Issue:6
Topics: Biomarkers; Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 2; Dietary Carbohydr | 1996 |
Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs?Diabetes care, 1996, Volume: 19, Issue:5
Topics: Biomarkers; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Die | 1996 |
Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up.Diabetic medicine : a journal of the British Diabetic Association, 1996, Volume: 13, Issue:5
Topics: Aged; Albuminuria; Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cho | 1996 |
Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin-dependent diabetes mellitus.The Annals of pharmacotherapy, 1996, Volume: 30, Issue:5
Topics: Adult; Aged; Aging; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucose Tolerance T | 1996 |
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.Diabetes care, 1996, Volume: 19, Issue:8
Topics: Analysis of Variance; Animals; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; | 1996 |
Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:2
Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Femal | 1996 |
Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.Diabetic medicine : a journal of the British Diabetic Association, 1996, Volume: 13, Issue:9 Suppl 6
Topics: Administration, Oral; Biological Availability; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mel | 1996 |
Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Femal | 1996 |
Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; G | 1996 |
The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Clamp Technique; G | 1996 |
The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Fem | 1996 |
Comparison of different insulin regimens in elderly patients with NIDDM.Diabetes care, 1996, Volume: 19, Issue:12
Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL | 1996 |
NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment.Diabetologia, 1996, Volume: 39, Issue:12
Topics: Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; | 1996 |
[Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. Possible selection criteria].Minerva endocrinologica, 1996, Volume: 21, Issue:2
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Administration Schedul | 1996 |
Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group.Diabetes, 1997, Volume: 46, Issue:3
Topics: Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Confidence Inte | 1997 |
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitus.Journal of clinical pharmacology, 1997, Volume: 37, Issue:2
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Glucose; Cross-Over Stud | 1997 |
Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.Diabetes care, 1997, Volume: 20, Issue:4
Topics: Adult; Black or African American; Black People; Blood Glucose; C-Peptide; Combined Modality Therapy; | 1997 |
The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone.Diabetes care, 1997, Volume: 20, Issue:5
Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diarrhea; Diet, Diabetic; | 1997 |
Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM.Diabetes care, 1997, Volume: 20, Issue:5
Topics: Acetylcholine; Adult; Aged; Angiotensin II; Blood Glucose; Blood Pressure; Cholesterol; Cross-Over S | 1997 |
Acute effects of oral glibenclamide on blood pressure and forearm vascular resistance in diabetics.Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:5
Topics: Adenosine Triphosphate; Adult; Aged; Blood Glucose; Blood Pressure; Cross-Over Studies; Diabetes Mel | 1997 |
Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study.Diabetes research and clinical practice, 1997, Volume: 37, Issue:1
Topics: Blood Glucose; Body Constitution; Body Mass Index; C-Peptide; Cholesterol; Diabetes Mellitus, Type 2 | 1997 |
Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM.Diabetes care, 1997, Volume: 20, Issue:9
Topics: Acarbose; Analysis of Variance; Circadian Rhythm; Diabetes Mellitus, Type 2; Double-Blind Method; Fe | 1997 |
Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?Diabetes, 1997, Volume: 46, Issue:10
Topics: Blood Glucose; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Fasting; Food; Glyburide; | 1997 |
[Estimation of different models of insulin therapy in noninsulin-dependent diabetes mellitus].Przeglad lekarski, 1997, Volume: 54, Issue:5
Topics: Adult; Aged; Creatinine; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Glyburide; | 1997 |
A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.JAMA, 1998, Jan-14, Volume: 279, Issue:2
Topics: Age Factors; Aged; Analysis of Variance; Blood Chemical Analysis; Blood Glucose; Diabetes Mellitus, | 1998 |
Acute effects of oral glibenclamide on blood pressure and forearm vascular resistance in diabetics.Clinical and experimental pharmacology & physiology, 1998, Volume: 25, Issue:2
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Diazoxide | 1998 |
UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group.Diabetes care, 1998, Volume: 21, Issue:1
Topics: Blood Glucose; Blood Pressure; Chlorpropamide; Cholesterol; Clinical Protocols; Diabetes Mellitus, T | 1998 |
The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.Diabetic medicine : a journal of the British Diabetic Association, 1998, Volume: 15, Issue:3
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Exercise; Glucagon; Glyburide; Humans; H | 1998 |
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.Diabetic medicine : a journal of the British Diabetic Association, 1998, Volume: 15, Issue:4
Topics: Adult; Blood Glucose; Body Mass Index; Chlorpropamide; Diabetes Mellitus, Type 2; Fasting; Female; G | 1998 |
Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:5
Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhi | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131
Topics: Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburi | 1998 |
Effects of glibenclamide on blood pressure and cardiovascular responsiveness in non-insulin dependent diabetes mellitus.Journal of hypertension, 1998, Volume: 16, Issue:5
Topics: Acetylcholine; Adult; Aged; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind | 1998 |
Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia.International journal of clinical & laboratory research, 1998, Volume: 28, Issue:3
Topics: Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Fatty Acids, Unsaturated; Female; Gl | 1998 |
[Clinical study of glibenclamide in combination with kelening treatment in non-insulin dependent diabetes mellitus].Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1997, Volume: 17, Issue:1
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Drugs, Chinese Herbal; Female; G | 1997 |
Observations on the effect of glibenclamide on noninvasive clinical parameters of myocardial ischemia.Cardiovascular drugs and therapy, 1998, Volume: 12, Issue:4
Topics: Blood Pressure; Coronary Disease; Diabetes Mellitus, Type 2; Glyburide; Humans; Insulin; Myocardial | 1998 |
Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?Journal of endocrinological investigation, 1998, Volume: 21, Issue:11
Topics: Adult; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Resistance; Drug The | 1998 |
Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.Annals of internal medicine, 1999, Mar-02, Volume: 130, Issue:5
Topics: Albuminuria; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Drug Administratio | 1999 |
[Short-term intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type 2 diabetes (non-insulin-dependent)].Polskie Archiwum Medycyny Wewnetrznej, 1998, Volume: 99, Issue:6
Topics: Aged; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combin | 1998 |
A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.Diabetes care, 1999, Volume: 22, Issue:3
Topics: Adult; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; G | 1999 |
[Clinical report of 60 cases of diabetic cardio-vascular autonomous neuropathy by stasis removing treatment of combined traditional and Western medicine].Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1997, Volume: 17, Issue:10
Topics: Adult; Aged; Autonomic Nervous System Diseases; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dr | 1997 |
Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients.JPMA. The Journal of the Pakistan Medical Association, 1998, Volume: 48, Issue:11
Topics: Adult; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic | 1998 |
A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.Diabetes care, 1999, Volume: 22, Issue:5
Topics: Adult; Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Meth | 1999 |
Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).Arzneimittel-Forschung, 1999, Volume: 49, Issue:4
Topics: Adult; Amyloid; Blood Glucose; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female | 1999 |
Repaglinide versus glyburide: a one-year comparison trial.Diabetes research and clinical practice, 1999, Volume: 43, Issue:3
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; | 1999 |
Effect of troglitazone on body fat distribution in type 2 diabetic patients.Diabetes care, 1999, Volume: 22, Issue:6
Topics: Abdomen; Adipose Tissue; Blood Glucose; Blood Pressure; Body Mass Index; Chromans; Diabetes Mellitus | 1999 |
A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas.European journal of clinical pharmacology, 1999, Volume: 55, Issue:3
Topics: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Humans | 1999 |
Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus.Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:1
Topics: Adult; Blood Pressure; Chromans; Diabetes Mellitus, Type 2; Female; Glyburide; Hemodynamics; Humans; | 1999 |
A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.Acta diabetologica, 1999, Volume: 36, Issue:1-2
Topics: Blood Glucose; Body Weight; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind M | 1999 |
The effects of glibenclamide on serum lipids and lipoproteins in type II non-insulin dependent diabetes mellitus.JPMA. The Journal of the Pakistan Medical Association, 1999, Volume: 49, Issue:4
Topics: Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agent | 1999 |
The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.Diabetic medicine : a journal of the British Diabetic Association, 1999, Volume: 16, Issue:10
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; | 1999 |
Effects of glibenclamide on postprandial coagulation activation.Nutrition, metabolism, and cardiovascular diseases : NMCD, 1999, Volume: 9, Issue:4
Topics: Administration, Oral; Aged; Analysis of Variance; Area Under Curve; Blood Coagulation; Cross-Over St | 1999 |
Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin.Diabetic medicine : a journal of the British Diabetic Association, 1999, Volume: 16, Issue:12
Topics: Aged; Aging; Antithrombin III; Blood Glucose; Blood Platelets; Cholesterol, HDL; Cholesterol, LDL; D | 1999 |
Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes.European journal of clinical pharmacology, 2000, Volume: 55, Issue:10
Topics: Adult; Aged; Asian People; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, T | 2000 |
Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients.Metabolism: clinical and experimental, 2000, Volume: 49, Issue:2
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Femal | 2000 |
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:1
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mel | 2000 |
Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide.Metabolism: clinical and experimental, 2000, Volume: 49, Issue:2 Suppl 1
Topics: Adult; Aged; Blood Platelets; Collagen; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy | 2000 |
Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.The American journal of the medical sciences, 2000, Volume: 319, Issue:3
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Glycated Hemogl | 2000 |
Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.Diabetes care, 2000, Volume: 23, Issue:2
Topics: Asian People; Bezafibrate; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypertriglyceridemi | 2000 |
Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.Diabetes care, 2000, Volume: 23, Issue:3
Topics: Adult; Aged; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Administration Schedule; D | 2000 |
Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.Diabetes care, 2000, Volume: 23, Issue:3
Topics: Blood Glucose; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Dou | 2000 |
Efficacy and safety of single versus multiple daily doses of glibenclamide in type 2 diabetes mellitus.Diabetes research and clinical practice, 2000, Volume: 49, Issue:2-3
Topics: Adult; Blood Glucose; Body Mass Index; Body Weight; Cross-Over Studies; Diabetes Mellitus, Type 2; D | 2000 |
Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.Diabetes care, 2000, Volume: 23, Issue:9
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; F | 2000 |
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.Diabetologia, 2000, Volume: 43, Issue:9
Topics: Acute-Phase Proteins; Albuminuria; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Over Studies | 2000 |
Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:11
Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Th | 2000 |
Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes.European journal of clinical pharmacology, 2000, Volume: 56, Issue:9-10
Topics: Adult; Aged; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glucose Tole | 2000 |
Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes.Diabetes, obesity & metabolism, 1999, Volume: 1, Issue:4
Topics: Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Ch | 1999 |
Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes.Metabolism: clinical and experimental, 2001, Volume: 50, Issue:3
Topics: Acute-Phase Proteins; Blood Glucose; Blood Proteins; C-Reactive Protein; Complement Activation; Comp | 2001 |
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics.Diabetes research and clinical practice, 2001, Volume: 51, Issue:3
Topics: 1-Deoxynojirimycin; Analysis of Variance; Blood Glucose; Combined Modality Therapy; Diabetes Mellitu | 2001 |
Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients.Metabolism: clinical and experimental, 2001, Volume: 50, Issue:4
Topics: Adult; Aged; Bezafibrate; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypog | 2001 |
Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.Diabetes research and clinical practice, 2001, Volume: 52, Issue:2
Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gliclazide; Glyburide; H | 2001 |
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia.Diabetes care, 2001, Volume: 24, Issue:4
Topics: Aged; Aged, 80 and over; Blood Pressure; Brachial Artery; Diabetes Mellitus, Type 2; Diet, Diabetic; | 2001 |
Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.Diabetes care, 2001, Volume: 24, Issue:6
Topics: Aged; Area Under Curve; Blood Glucose; C-Peptide; Cyclohexanes; Diabetes Mellitus, Type 2; Diet, Dia | 2001 |
Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus.Japanese circulation journal, 2001, Volume: 65, Issue:6
Topics: Adenosine Triphosphate; Aged; Blood Glucose; Case-Control Studies; Chromans; Coronary Circulation; D | 2001 |
Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:4
Topics: Albuminuria; Animals; Blood Pressure; Chromans; Collagen; Creatinine; Diabetes Mellitus, Type 2; Dia | 2001 |
[Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].Terapevticheskii arkhiv, 2001, Volume: 73, Issue:4
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Follow-Up Studies; Free Radical Scavengers; G | 2001 |
Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in Type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:7
Topics: Blood Glucose; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; Glyburide; Glycated H | 2001 |
Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:10
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Cholesterol; Chylomicrons; Coronary Disease; Diab | 2001 |
Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms.The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:11
Topics: Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Epinephrine; Female; Glyburide; Gly | 2001 |
Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes.Clinica chimica acta; international journal of clinical chemistry, 2001, Volume: 314, Issue:1-2
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Erythrocyte Membrane; Glyburide; Glyca | 2001 |
Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.Clinical therapeutics, 2001, Volume: 23, Issue:10
Topics: Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglo | 2001 |
Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus.The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:12
Topics: Aged; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Toleranc | 2001 |
Effect of pioglitazone on dyslipidemia in hemodialysis patients with type 2 diabetes.Renal failure, 2001, Volume: 23, Issue:6
Topics: Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperli | 2001 |
Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.Clinical therapeutics, 2002, Volume: 24, Issue:1
Topics: Aged; Aged, 80 and over; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; | 2002 |
Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans.Circulation research, 2002, Feb-08, Volume: 90, Issue:2
Topics: Adenosine; Adenosine Triphosphate; Blood Flow Velocity; Blood Glucose; Coronary Angiography; Coronar | 2002 |
Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.The Journal of the Association of Physicians of India, 2001, Volume: 49Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gliclazide; Glyburide; Humans; Hypoglycemic | 2001 |
Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.Diabetes research and clinical practice, 2002, Volume: 55, Issue:3
Topics: Acarbose; Blood Glucose; Body Mass Index; Circadian Rhythm; Diabetes Mellitus, Type 2; Double-Blind | 2002 |
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes.Diabetes, 2002, Volume: 51, Issue:3
Topics: Cardiomyopathies; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipyridamole; Echocardiography, Str | 2002 |
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:2
Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Blood Pressure; Body Mass Index; Body Weight; C-Pep | 2002 |
Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.Diabetes care, 2002, Volume: 25, Issue:3
Topics: Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Chromans; D | 2002 |
Microcirculatory effects of KATP channel blockade by sulphonylurea derivatives in humans.European journal of clinical investigation, 2002, Volume: 32, Issue:3
Topics: Adenosine Triphosphate; Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glyb | 2002 |
Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes.Diabetes care, 2002, Volume: 25, Issue:4
Topics: Abdomen; Adipose Tissue; Adult; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cholestero | 2002 |
A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment.Journal of internal medicine, 2002, Volume: 251, Issue:4
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Sche | 2002 |
Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.Diabetes, obesity & metabolism, 2002, Volume: 4, Issue:3
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; G | 2002 |
Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy.Diabetes research (Edinburgh, Scotland), 1992, Volume: 19, Issue:2
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Glucose Clamp Technique; Glybu | 1992 |
Morning or bed-time insulin with or without glibenclamide in elderly type 2 diabetic patients unresponsive to oral antidiabetic agents.Diabetes research and clinical practice, 1992, Volume: 18, Issue:3
Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mell | 1992 |
Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.Diabetes care, 1992, Volume: 15, Issue:8
Topics: Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glic | 1992 |
Evaluation of glipizide and glyburide in a health maintenance organization.The Annals of pharmacotherapy, 1992, Volume: 26, Issue:10
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Costs; Evaluation Studies as Topic; Fema | 1992 |
A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients.Metabolism: clinical and experimental, 1992, Volume: 41, Issue:12
Topics: Adult; Blood Glucose; Body Mass Index; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dietary | 1992 |
Chronic sulfonylurea therapy augments basal and meal-stimulated insulin secretion while attenuating insulin responses to sulfonylurea per se.Diabetes care, 1992, Volume: 15, Issue:11
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Typ | 1992 |
Efficacy of 6 months monotherapy with glucosidase inhibitor Acarbose versus sulphonylurea glibenclamide on metabolic control of dietary treated type II diabetics (NIDDM).Hormone and metabolic research. Supplement series, 1992, Volume: 26Topics: Acarbose; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycoside Hydrolase Inhibitor | 1992 |
Comparison of combined therapies in treatment of secondary failure to glyburide.Diabetes care, 1992, Volume: 15, Issue:4
Topics: Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Administra | 1992 |
Maintenance of sulfonylurea responsiveness in NIDDM. Randomized double-blind study of intermittent glyburide therapy.Diabetes care, 1992, Volume: 15, Issue:5
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Admi | 1992 |
Hyperproinsulinemia in type II diabetes.Diabetes care, 1992, Volume: 15, Issue:5
Topics: Cross Reactions; Diabetes Mellitus, Type 2; Glyburide; Humans; Immunoassay; Insulin; Insulin, Isopha | 1992 |
Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM.Diabetes care, 1992, Volume: 15, Issue:7
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Humans; Insu | 1992 |
[Model of therapeutic programming in NIDDM diabetes].Minerva medica, 1992, Volume: 83, Issue:3
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin R | 1992 |
A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents.Diabetic medicine : a journal of the British Diabetic Association, 1992, Volume: 9, Issue:2
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Fasting; Female; Glyburide; Humans; Male; | 1992 |
[Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].La Clinica terapeutica, 1992, Volume: 140, Issue:3
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glybu | 1992 |
Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.The American journal of the medical sciences, 1992, Volume: 303, Issue:3
Topics: Adult; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Adm | 1992 |
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment.Diabetes, 1992, Volume: 41, Issue:8
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Gl | 1992 |
Effect of glyburide and omega 3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.The American journal of clinical nutrition, 1992, Volume: 56, Issue:2
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids; Fatty Acids, Omega-3; Glucagon; Glucose | 1992 |
Detection of glibenclamide in oral insulin capsules.Lancet (London, England), 1991, Aug-03, Volume: 338, Issue:8762
Topics: Administration, Oral; Adult; Blood Glucose; Capsules; Diabetes Mellitus, Type 2; Drug Contamination; | 1991 |
Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus.The American journal of cardiology, 1991, Apr-15, Volume: 67, Issue:9
Topics: Adult; Angina Pectoris; Blood Glucose; Cardiac Complexes, Premature; Coronary Disease; Diabetes Mell | 1991 |
Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patients.Diabetic medicine : a journal of the British Diabetic Association, 1991, Volume: 8, Issue:4
Topics: alpha-Macroglobulins; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; | 1991 |
Benefits and risks with glyburide and glipizide in elderly NIDDM patients.Diabetes care, 1992, Volume: 15, Issue:1
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Glipizide; Glybu | 1992 |
Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles.European journal of clinical pharmacology, 1991, Volume: 41, Issue:3
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Diabetes Mell | 1991 |
Could intranasal insulin be useful in the treatment of non-insulin-dependent diabetes mellitus?Diabetes research and clinical practice, 1991, Volume: 13, Issue:1-2
Topics: Administration, Intranasal; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation; Female | 1991 |
Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.Diabetes research and clinical practice, 1991, Volume: 14 Suppl 2Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Gliclazide; Glipizide; Gly | 1991 |
Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failure.Diabetes care, 1991, Volume: 14, Issue:11
Topics: Analysis of Variance; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; | 1991 |
Evaluation of a potential interaction between erythromycin and glyburide in diabetic volunteers.Journal of clinical pharmacology, 1991, Volume: 31, Issue:3
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Drug Interactions; Erythromycin; Female; Glyburide; | 1991 |
Comparative effects of diet or glibenclamide on insulin secretion and action in non-obese NIDDM.Diabetes research and clinical practice, 1991, Volume: 11, Issue:2
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Erythrocytes; Female; Glucose Tolerance Te | 1991 |
[The effects of insulin combined with glibenclamide on glucose and lipid metabolism in patients with Type II diabetes mellitus].Nederlands tijdschrift voor geneeskunde, 1991, Jun-15, Volume: 135, Issue:24
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glucose; Glyburide; Glycated Hemoglobin; Humans; Insulin; L | 1991 |
Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non-insulin-dependent diabetes mellitus.Diabete & metabolisme, 1991, Volume: 17, Issue:1 Pt 2
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Com | 1991 |
The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM).Diabete & metabolisme, 1991, Volume: 17, Issue:1 Pt 2
Topics: Administration, Oral; Blood Glucose; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug | 1991 |
Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus.Diabete & metabolisme, 1991, Volume: 17, Issue:1 Pt 2
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glyb | 1991 |
Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.Diabete & metabolisme, 1991, Volume: 17, Issue:1 Pt 2
Topics: Adult; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Humans; Insulin; Metformin; | 1991 |
An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.Journal of clinical pharmacology, 1990, Volume: 30, Issue:2
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Femal | 1990 |
Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?Annals of internal medicine, 1990, May-01, Volume: 112, Issue:9
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Human | 1990 |
Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes.International journal of clinical pharmacology, therapy, and toxicology, 1990, Volume: 28, Issue:4
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Galactans | 1990 |
Insulin and sulphonylurea in the therapy of type 2 diabetes.Diabetes research and clinical practice, 1990, Volume: 8, Issue:3
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Me | 1990 |
[Insulin-sulfonylurea combination therapy in secondary therapy failure with sulfonylurea compounds. Randomized study between evening and morning intermediary insulin administration using the Novo Pen semi-automatic insulin injector].Schweizerische medizinische Wochenschrift, 1990, Jul-10, Volume: 120, Issue:27-28
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Drug Tolerance; Fe | 1990 |
Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.British journal of clinical pharmacology, 1990, Volume: 29, Issue:6
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Blood Glucose; Chromatography, Gas; Chromatogr | 1990 |
Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:8
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fol | 1990 |
[Comparison of the effect and tolerability of two glibenclamide preparations with different release rates].Arzneimittel-Forschung, 1990, Volume: 40, Issue:10
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Hemoglobin A | 1990 |
Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.Diabetologia, 1990, Volume: 33, Issue:11
Topics: Administration, Oral; C-Peptide; Circadian Rhythm; Delayed-Action Preparations; Diabetes Mellitus, T | 1990 |
Comparison of secondary failure rate between three second generation sulphonylureas.Diabetes research (Edinburgh, Scotland), 1990, Volume: 13, Issue:1
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Follow-Up Studies; Gliclazide; Glipizide; | 1990 |
Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.Diabetic medicine : a journal of the British Diabetic Association, 1990, Volume: 7, Issue:2
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Diabetes | 1990 |
Fenfluramine increases insulin action in patients with NIDDM.Diabetes care, 1989, Volume: 12, Issue:4
Topics: Adult; Aged; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fem | 1989 |
Clinical comparison of glipizide and glyburide.Diabetes care, 1989, Volume: 12, Issue:1
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Fasting; Glipizide; Glyburide; H | 1989 |
[Results of clinical trials with the gluconeogenesis inhibitor 2-(3-methylcinnamylhydrazono)-propionate (MCHP)].Klinische Wochenschrift, 1989, Apr-17, Volume: 67, Issue:8
Topics: Aged; Aged, 80 and over; Blood Glucose; Cinnamates; Diabetes Mellitus, Type 2; Drug Evaluation; Fema | 1989 |
Effects of combined insulin-sulfonylurea therapy in type II patients.Diabetes care, 1989, Volume: 12, Issue:6
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Me | 1989 |
Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus.Diabetologia, 1989, Volume: 32, Issue:8
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; D | 1989 |
[Clinical study comparing the effectiveness and tolerance of 2 current and one new glibenclamide formulation].Wiener medizinische Wochenschrift (1946), 1989, Jun-30, Volume: 139, Issue:12
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dose-Response R | 1989 |
A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy.Diabetic medicine : a journal of the British Diabetic Association, 1989, Volume: 6, Issue:6
Topics: Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diet, Diabetic; Fasti | 1989 |
U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study.Diabetes, 1985, Volume: 34, Issue:8
Topics: Adult; Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Gl | 1985 |
The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 1988, Volume: 5, Issue:7
Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Diabetes M | 1988 |
Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.Diabete & metabolisme, 1986, Volume: 12, Issue:1
Topics: Blood Glucose; Body Weight; C-Peptide; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; | 1986 |
Platelet behaviour in non-insulin-dependent diabetes--influence of vascular complications, treatment and metabolic control.Thrombosis and haemostasis, 1986, Jun-30, Volume: 55, Issue:3
Topics: Adenosine Diphosphate; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Epinephrin | 1986 |
[Mechanism of action of combined administration of glibenclamide and insulin in type II diabetics with secondary failure of oral treatment].Klinische Wochenschrift, 1986, Oct-15, Volume: 64, Issue:20
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, T | 1986 |
Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:2
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Compounding; Female; | 1987 |
Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial.JAMA, 1987, May-08, Volume: 257, Issue:18
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-B | 1987 |
[Long-term effect of combination glibenclamide-insulin treatment in the secondary failure of sulfonylurea therapy--results of a one-year double blind study].Wiener klinische Wochenschrift, 1987, Sep-11, Volume: 99, Issue:17
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; H | 1987 |
Serum C-peptide after 6 months on glibenclamide remains higher than during insulin treatment.Diabetes research (Edinburgh, Scotland), 1987, Volume: 6, Issue:2
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Insulin; Male; Metform | 1987 |
Combined glyburide and insulin therapy in type II diabetes.Diabetes research (Edinburgh, Scotland), 1987, Volume: 6, Issue:2
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Evaluat | 1987 |
Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.Annals of internal medicine, 1988, Volume: 108, Issue:3
Topics: Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gly | 1988 |
Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.Diabetes research and clinical practice, 1988, Jan-07, Volume: 4, Issue:2
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 1988 |
Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy.Acta medica Scandinavica, 1988, Volume: 223, Issue:2
Topics: Adult; Aged; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, | 1988 |
[Effectiveness of combined treatment with glibenclamide and insulin in secondary sulfonylurea failure. A controlled multicenter double-blind clinical trial].Deutsche medizinische Wochenschrift (1946), 1988, Apr-22, Volume: 113, Issue:16
Topics: Adult; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug | 1988 |
Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents.Diabetologia, 1988, Volume: 31, Issue:4
Topics: Administration, Oral; Aged; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug C | 1988 |
Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term double-blind, placebo-controlled trial.Clinical pharmacology and therapeutics, 1988, Volume: 44, Issue:5
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therap | 1988 |
New modalities in diabetes treatment.The American journal of medicine, 1988, Nov-28, Volume: 85, Issue:5A
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Humans; Insulin | 1988 |
Combination of two sulfonylureas. Does it make sense.Diabetes care, 1988, Volume: 11, Issue:9
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, | 1988 |
[Combination therapy with insulin/sulfonylurea in the long-term therapy of type II diabetes following "secondary failure"].Klinische Wochenschrift, 1988, Nov-01, Volume: 66, Issue:21
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Administration | 1988 |
Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.Clinical therapeutics, 1988, Volume: 10, Issue:3
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Glycated Hemoglobin; Hepatit | 1988 |
Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.Acta medica Scandinavica, 1985, Volume: 217, Issue:1
Topics: Blood Glucose; Body Weight; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-B | 1985 |
The 24-hour effects of glyburide and chlorpropamide after chronic treatment of type II diabetic patients.The American journal of the medical sciences, 1985, Volume: 289, Issue:5
Topics: Adult; Aged; Blood Glucose; Chlorpropamide; Cholesterol; Diabetes Mellitus, Type 2; Drug Evaluation; | 1985 |
[Effect of acarbose on carbohydrate and lipid metabolism in type II diabetes with secondary failure].Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1985, Volume: 45, Issue:2
Topics: Acarbose; Aged; Blood Glucose; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dru | 1985 |
Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus.The American journal of medicine, 1985, Aug-23, Volume: 79, Issue:2B
Topics: Adult; Aged; Blood Glucose; Chlorpropamide; Clinical Trials as Topic; Combined Modality Therapy; Dia | 1985 |
Once-daily use of glyburide.The American journal of medicine, 1985, Sep-20, Volume: 79, Issue:3B
Topics: Blood Glucose; Body Weight; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Administration Schedule; | 1985 |
Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.The American journal of medicine, 1985, Sep-20, Volume: 79, Issue:3B
Topics: Blood Glucose; Blood Proteins; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Doubl | 1985 |
Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.Annals of clinical research, 1985, Volume: 17, Issue:3
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Do | 1985 |
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.European journal of clinical pharmacology, 1985, Volume: 28, Issue:6
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythro | 1985 |
Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.Arzneimittel-Forschung, 1985, Volume: 35, Issue:10
Topics: Adult; Aged; Blood Glucose; Chlorpropamide; Creatinine; Diabetes Mellitus, Type 2; Electrolytes; Fem | 1985 |
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.Current medical research and opinion, 1985, Volume: 9, Issue:10
Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Gl | 1985 |
[Combined treatment of type-2 diabetics with insulin and glibenclamide after secondary drug failure. Double-blind, insulin-placebo-controlled crossover study].Deutsche medizinische Wochenschrift (1946), 1985, Dec-20, Volume: 110, Issue:51-52
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Me | 1985 |
| Article | Year |
|---|
Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.Bioorganic & medicinal chemistry, 2009, May-01, Volume: 17, Issue:9
Topics: Animals; Benzothiazoles; Blood Glucose; Computer Simulation; Diabetes Mellitus, Experimental; Diabet | 2009 |
Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.Bioorganic & medicinal chemistry, 2009, Jul-15, Volume: 17, Issue:14
Topics: Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dos | 2009 |
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs.Bioorganic & medicinal chemistry, 2009, Aug-01, Volume: 17, Issue:15
Topics: Animals; Aorta; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin; Islets o | 2009 |
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.Journal of natural products, 2011, Mar-25, Volume: 74, Issue:3
Topics: Acarbose; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Me | 2011 |
Discovery of phenylpropanoic acid derivatives containing polar functionalities as potent and orally bioavailable G protein-coupled receptor 40 agonists for the treatment of type 2 diabetes.Journal of medicinal chemistry, 2012, Apr-26, Volume: 55, Issue:8
Topics: Animals; Calcium; Caspases; Cell Survival; CHO Cells; Cricetinae; Cyclic S-Oxides; Diabetes Mellitus | 2012 |
Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.Journal of medicinal chemistry, 2012, Sep-13, Volume: 55, Issue:17
Topics: Animals; Blood Glucose; Cell Line, Tumor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2 | 2012 |
Design, synthesis and biological activity of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists.Bioorganic & medicinal chemistry, 2015, Nov-15, Volume: 23, Issue:22
Topics: Acetates; Animals; Binding Sites; Calcium; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Typ | 2015 |
Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.European journal of medicinal chemistry, 2016, May-04, Volume: 113Topics: Animals; Blood Glucose; CHO Cells; Cricetulus; Diabetes Mellitus, Experimental; Diabetes Mellitus, T | 2016 |
Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.Bioorganic & medicinal chemistry, 2016, May-01, Volume: 24, Issue:9
Topics: Administration, Oral; Animals; Biological Availability; Diabetes Mellitus, Type 2; Disease Models, A | 2016 |
Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.European journal of medicinal chemistry, 2017, Sep-29, Volume: 138Topics: Acetates; Animals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Discovery; Fema | 2017 |
Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold.European journal of medicinal chemistry, 2019, Oct-01, Volume: 179Topics: Acetates; Animals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Design; Glucose | 2019 |
Total Synthesis of Glipizide and Glibenclamide in Continuous Flow.Chemistry (Weinheim an der Bergstrasse, Germany), 2021, Nov-17, Volume: 27, Issue:64
Topics: Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin | 2021 |
Bridelia ferruginea Benth. (Euphorbiaceae) mitigates oxidative imbalance and lipotoxicity, with concomitant modulation of insulin signaling pathways via GLUT4 upregulation in hepatic tissues of diabetic rats.Journal of ethnopharmacology, 2022, Feb-10, Volume: 284Topics: Animals; Catalytic Domain; Diabetes Mellitus, Type 2; Euphorbiaceae; Gene Expression Regulation; Glu | 2022 |
Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 145Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug | 2022 |
Effects of Combined Current drug discovery technologies, 2022, Volume: 19, Issue:5
Topics: Animals; Aryldialkylphosphatase; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2022 |
Hypoglycemic, hypolipidemic and hepatoprotective effects of Hormone molecular biology and clinical investigation, 2022, Sep-01, Volume: 43, Issue:3
Topics: Alpinia; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glyburi | 2022 |
Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.Diabetes, obesity & metabolism, 2022, Volume: 24, Issue:8
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glyburide; Humans; Hypoglycemic Agents; Insulin; | 2022 |
Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.PloS one, 2022, Volume: 17, Issue:7
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases | 2022 |
Polymeric micelles loaded with glyburide and vanillic acid: I. Formulation development, in-vitro characterization and bioavailability studies.International journal of pharmaceutics, 2022, Aug-25, Volume: 624Topics: Biological Availability; Caco-2 Cells; Diabetes Mellitus, Type 2; Drug Carriers; Glucose; Glyburide; | 2022 |
Efficacy and safety of nanoparticles of glibenclamide and organomodified layered double hydroxides in diabetics rats.International journal of pharmaceutics, 2023, Mar-05, Volume: 634Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glyburide; Hydro | 2023 |
Idealistic, realistic, and unrealistic expectations of pharmacological treatment in persons with type 2 diabetes in primary care.Frontiers in public health, 2023, Volume: 11Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Glyburide; Humans; Insulin; Metformin; Motivatio | 2023 |
Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Journal of pharmaceutical sciences, 2023, Volume: 112, Issue:5
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Gliclazide; | 2023 |
Evaluation of acute oral toxicity, anti-diabetic and antioxidant effects of Aloe vera flowers extract.Journal of ethnopharmacology, 2023, Jun-12, Volume: 309Topics: Aloe; Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes | 2023 |
Dimethyl fumarate-mediated Nrf2/ARE pathway activation and glibenclamide-mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes-associated fatty liver in rats by mitigating oxidative stress and inflammation.Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:7
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dimethyl Fumarate | 2023 |
ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control?Journal of pediatric endocrinology & metabolism : JPEM, 2023, Jun-27, Volume: 36, Issue:6
Topics: Child; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Infant, Newborn; Insulin; Mutation; Sul | 2023 |
[Cost-effectiveness of treatment of type 2 diabetes mellitus in México].Revista medica del Instituto Mexicano del Seguro Social, 2023, Mar-01, Volume: 61, Issue:2
Topics: Cost-Benefit Analysis; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypogl | 2023 |
Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease.Behavioural brain research, 2020, 02-03, Volume: 379Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Type 2 | 2020 |
Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus.Diabetes research and clinical practice, 2020, Volume: 162Topics: Administration, Oral; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV In | 2020 |
Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes.Scientific reports, 2020, 02-24, Volume: 10, Issue:1
Topics: Aged; Antibodies, Viral; Antibody Affinity; Antibody Formation; Diabetes Mellitus, Type 2; Female; G | 2020 |
Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone.International journal of molecular sciences, 2020, Mar-19, Volume: 21, Issue:6
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Ele | 2020 |
Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection.Tuberculosis (Edinburgh, Scotland), 2020, Volume: 123Topics: Adult; Aged; Case-Control Studies; Cells, Cultured; Diabetes Mellitus, Type 2; Dinoprostone; Female; | 2020 |
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations.Scientific reports, 2020, 06-22, Volume: 10, Issue:1
Topics: Aged; Cohort Studies; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburid | 2020 |
The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy.Vascular health and risk management, 2020, Volume: 16Topics: Biomarkers; Blood Glucose; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Diabetic Nephropathie | 2020 |
Glyburide Use in Older Adults: Pharmacy Claims Data Analysis of a Regional Healthcare Organization.Journal of the American Geriatrics Society, 2020, Volume: 68, Issue:10
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glyburide; Health Plan Implementation; H | 2020 |
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans.Metabolism: clinical and experimental, 2021, Volume: 114Topics: Adrenergic Neurons; Aged; Blood Glucose; Cell Dedifferentiation; Diabetes Mellitus, Type 2; Female; | 2021 |
Synergistic Effect of Omega-3 Fatty Acids and Oral-Hypoglycemic Drug on Lipid Normalization through Modulation of Hepatic Gene Expression in High Fat Diet with Low Streptozotocin-Induced Diabetic Rats.Nutrients, 2020, Nov-27, Volume: 12, Issue:12
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; | 2020 |
Monogenic diabetes: a new pathogenic variant of HNF1A gene.BMJ case reports, 2021, Jan-20, Volume: 14, Issue:1
Topics: Adolescent; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Glucose Tolerance Test; Glybu | 2021 |
Stink bean (Archives of physiology and biochemistry, 2023, Volume: 129, Issue:1
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Di | 2023 |
Glyburide attenuates B(a)p and LPS-induced inflammation-related lung tumorigenesis in mice.Environmental toxicology, 2021, Volume: 36, Issue:8
Topics: Animals; Benzo(a)pyrene; Carcinogenesis; Diabetes Mellitus, Type 2; Glyburide; Inflammasomes; Inflam | 2021 |
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States.Diabetes, obesity & metabolism, 2021, Volume: 23, Issue:10
Topics: Adult; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glyburide; Humans; Hyp | 2021 |
Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.Clinical pharmacology and therapeutics, 2022, Volume: 111, Issue:1
Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors | 2022 |
Synthesis of a novel glibenclamide-pioglitazone hybrid compound and its effects on glucose homeostasis in normal and insulin-resistant rats.Bioorganic chemistry, 2021, Volume: 114Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glyburide; Home | 2021 |
Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes.Biological trace element research, 2017, Volume: 180, Issue:2
Topics: Animals; Blood Glucose; Chromium; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dietary Supp | 2017 |
Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes.Drug research, 2017, Volume: 67, Issue:7
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Pepti | 2017 |
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017, Nov-15, Volume: 109STopics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Carbazoles; Carvedilol; Cytochrome P-450 CYP2C9; | 2017 |
Effectiveness and clinical inertia in patients with antidiabetic therapy.International journal of clinical practice, 2017, Volume: 71, Issue:6
Topics: Adult; Aged; Colombia; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glyburide; Glycat | 2017 |
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.Epidemiology (Cambridge, Mass.), 2017, Volume: 28, Issue:6
Topics: Adult; Aged; Cohort Studies; Diabetes Mellitus, Type 2; Emergency Service, Hospital; Female; Glipizi | 2017 |
Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337.Diabetes care, 2017, Volume: 40, Issue:8
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; In | 2017 |
Response to Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337.Diabetes care, 2017, Volume: 40, Issue:8
Topics: Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glyburide; Humans; Hypoglycemic Agents; In | 2017 |
Selective ER-α agonist alleviates vascular endothelial dysfunction in ovariectomized type 2 diabetic rats.Molecular and cellular endocrinology, 2018, 01-15, Volume: 460Topics: Acetylcholine; Animals; Aorta; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Experiment | 2018 |
Peppermint essential oil alleviates hyperglycemia caused by streptozotocin- nicotinamide-induced type 2 diabetes in rats.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 95Topics: Administration, Oral; Animals; Antioxidants; Diabetes Mellitus, Type 2; Free Radical Scavengers; Gly | 2017 |
Pulse pressure and diabetes treatments: Blood pressure and pulse pressure difference among glucose lowering modality groups in type 2 diabetes.Medicine, 2018, Volume: 97, Issue:6
Topics: Adult; Blood Pressure; Blood Pressure Determination; Cohort Studies; Diabetes Mellitus, Type 2; Drug | 2018 |
Genetic Variants Identified from GWAS for Predisposition to Type 2 Diabetes Predict Sulfonylurea Drug Response.Current molecular medicine, 2017, Volume: 17, Issue:8
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genome-Wide Assoc | 2017 |
Structural insights into suppressor of cytokine signaling 1 protein- identification of new leads for type 2 diabetes mellitus.Journal of molecular recognition : JMR, 2018, Volume: 31, Issue:7
Topics: Amino Acid Sequence; Catalytic Domain; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Ag | 2018 |
Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.Current pharmaceutical design, 2018, Volume: 24, Issue:16
Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 2; Diffusion; Dose-Response Relationship, Dru | 2018 |
CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide.Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:6
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Cross-Sectional Studies; Cytochrome P-450 CYP2C9; Dia | 2018 |
A herbal treatment for type 2 diabetes adulterated with undisclosed drugs.Lancet (London, England), 2018, 06-16, Volume: 391, Issue:10138
Topics: Diabetes Mellitus, Type 2; Drug Contamination; Female; Glyburide; Humans; Hypoalbuminemia; Hypoglyce | 2018 |
Effects of amlodipine and valsartan on glibenclamide-treated streptozotocin-induced diabetic rats.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106Topics: Amlodipine; Animals; Antihypertensive Agents; Biomarkers; Blood Glucose; Diabetes Mellitus, Experime | 2018 |
Vindoline effectively ameliorated diabetes-induced hepatotoxicity by docking oxidative stress, inflammation and hypertriglyceridemia in type 2 diabetes-induced male Wistar rats.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 112Topics: Animals; Blood Glucose; Catharanthus; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2019 |
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis.Diabetes research and clinical practice, 2019, Volume: 152Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angio | 2019 |
Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.Pancreas, 2013, Volume: 42, Issue:4
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agen | 2013 |
Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.European journal of endocrinology, 2013, Volume: 169, Issue:1
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confounding Factors, Epidemiol | 2013 |
[Diabetes treatment in patients with chronic kidney disease].Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:21
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Substitution; Drug Therapy, Combinatio | 2013 |
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients.Diabetes care, 2013, Volume: 36, Issue:10
Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Endarterectomy, Carotid; Glyburide; Humans; Hy | 2013 |
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients.Diabetes care, 2013, Volume: 36, Issue:10
Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Endarterectomy, Carotid; Glyburide; Humans; Hy | 2013 |
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients.Diabetes care, 2013, Volume: 36, Issue:10
Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Endarterectomy, Carotid; Glyburide; Humans; Hy | 2013 |
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients.Diabetes care, 2013, Volume: 36, Issue:10
Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Endarterectomy, Carotid; Glyburide; Humans; Hy | 2013 |
The influence on DNA damage of glycaemic parameters, oral antidiabetic drugs and polymorphisms of genes involved in the DNA repair system.Mutagenesis, 2013, Volume: 28, Issue:5
Topics: Administration, Oral; Adult; Aged; Comet Assay; Cross-Sectional Studies; Diabetes Mellitus, Type 2; | 2013 |
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy.Diabetologia, 2013, Volume: 56, Issue:9
Topics: Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glipizide; Glyburide; Humans; Hypoglycemic Age | 2013 |
Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study.Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:1
Topics: Acute Coronary Syndrome; Aged; Alberta; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Typ | 2014 |
Vildagliptin monotherapy. To be avoided, like other DPP-4 inhibitors.Prescrire international, 2013, Volume: 22, Issue:138
Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glyburide; Humans; Hypogl | 2013 |
Severe hypoglycemia due to possible interaction between glibenclamide and sorafenib in a patient with hepatocellular carcinoma.Current drug safety, 2013, Volume: 8, Issue:2
Topics: Aged; Antineoplastic Agents; Blood Glucose; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Dr | 2013 |
Preparation and application of a molecularly imprinted polymer for determination of glibenclamide residues.Acta pharmaceutica (Zagreb, Croatia), 2013, Volume: 63, Issue:2
Topics: Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drug Industry; Glyburide; Humans; H | 2013 |
Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.Diabetes/metabolism research and reviews, 2013, Volume: 29, Issue:8
Topics: Administration, Oral; Adult; Aged; Cardiovascular Diseases; Cohort Studies; Comorbidity; Coronary Di | 2013 |
Influence of glibenclamide on outcome in patients with type 2 diabetes and traumatic brain injury.Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:10
Topics: Adult; Age Factors; Aged; Blood Glucose; Brain Injuries; Diabetes Mellitus, Type 2; Female; Glasgow | 2013 |
A case of glyburide-induced leukocytoclastic vasculitis.Dermatology online journal, 2013, Sep-14, Volume: 19, Issue:9
Topics: Aged; Biopsy; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Male; Vasculitis, L | 2013 |
Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection.Scientific reports, 2013, Nov-28, Volume: 3Topics: Burkholderia pseudomallei; Diabetes Mellitus, Type 2; Disease Susceptibility; Glyburide; Humans; Hyp | 2013 |
Blood glucose-lowering effect of Tectona grandis flowers in type 2 diabetic rats: a study on identification of active constituents and mechanisms for antidiabetic action.Journal of diabetes, 2014, Volume: 6, Issue:5
Topics: alpha-Amylases; alpha-Glucosidases; Animals; Biomarkers; Blood Glucose; Body Weight; Cell Line; Diab | 2014 |
[Diagnosis and treatment of type 2 diabetes from the perspective of guidelines].Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:21
Topics: Algorithms; Body Weight; Combined Modality Therapy; Cross-Sectional Studies; Diabetes Mellitus, Type | 2014 |
A 'picturesque' case of transition from subcutaneous to oral treatment in neonatal diabetes.BMJ case reports, 2014, May-14, Volume: 2014Topics: Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Female; Genetic Testing; Glyburide; | 2014 |
Hypoglycemic properties of some preparations and compounds from Artemisia ludoviciana Nutt.Journal of ethnopharmacology, 2014, Aug-08, Volume: 155, Issue:1
Topics: Administration, Oral; alpha-Glucosidases; Animals; Artemisia; Blood Glucose; Diabetes Mellitus, Expe | 2014 |
Administration of Lupinus albus gamma conglutin (Cγ) to n5 STZ rats augmented Ins-1 gene expression and pancreatic insulin content.Plant foods for human nutrition (Dordrecht, Netherlands), 2014, Volume: 69, Issue:3
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression; | 2014 |
Metformin/glibenclamide-related interstitial lung disease: a case report.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014, Jul-08, Volume: 31, Issue:2
Topics: Administration, Oral; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Substitution; | 2014 |
Evaluation approach can significantly influence oral glucose-lowering drugs total mortality risks in retrospective cohorts of type 2 diabetes mellitus patients.Current diabetes reviews, 2014, Volume: 10, Issue:5
Topics: Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Metform | 2014 |
Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.Acta physiologica (Oxford, England), 2015, Volume: 213, Issue:3
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Blood Glucose; Cells, Cultured; Diabetes Mellitu | 2015 |
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.Diabetes research and clinical practice, 2015, Volume: 107, Issue:1
Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combina | 2015 |
Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study.Journal of diabetes and its complications, 2015, Volume: 29, Issue:2
Topics: Aged; Aged, 80 and over; Alberta; Blue Cross Blue Shield Insurance Plans; Carbamates; Cardiovascular | 2015 |
Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus.Diabetes research and clinical practice, 2015, Volume: 107, Issue:3
Topics: Adult; Aged; Aged, 80 and over; Colombia; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypo | 2015 |
Within-class differences of the sulfonylureas should be accounted for.Diabetologia, 2015, Volume: 58, Issue:6
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; I | 2015 |
Assessment of in vivo and in vitro genotoxicity of glibenclamide in eukaryotic cells.PloS one, 2015, Volume: 10, Issue:3
Topics: Adult; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycem | 2015 |
Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter].Diabetologia, 2015, Volume: 58, Issue:6
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin; I | 2015 |
The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.Canadian journal of diabetes, 2015, Volume: 39, Issue:4
Topics: Aged; Aged, 80 and over; Cohort Studies; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Fem | 2015 |
The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.Diabetes care, 2015, Volume: 38, Issue:11
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Mal | 2015 |
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 102Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chemistry, P | 2016 |
Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes.Pharmacoepidemiology and drug safety, 2016, Volume: 25, Issue:10
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Dose-Re | 2016 |
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality.Diabetes research and clinical practice, 2016, Volume: 117Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Co | 2016 |
Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients.Pakistan journal of pharmaceutical sciences, 2016, Volume: 29, Issue:4 Suppl
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; | 2016 |
Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.Epidemiology (Cambridge, Mass.), 2017, Volume: 28, Issue:3
Topics: Area Under Curve; Carbamates; Cyclohexanes; Databases, Factual; Diabetes Mellitus, Type 2; Drug Inte | 2017 |
Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats.Pharmaceutical biology, 2017, Volume: 55, Issue:1
Topics: Acetates; Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Ty | 2017 |
All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus.Archives of Iranian medicine, 2017, Volume: 20, Issue:3
Topics: Aged; Cardiovascular Diseases; Cause of Death; Cohort Studies; Coronary Angiography; Coronary Artery | 2017 |
Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:2
Topics: Blotting, Western; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Ce | 2009 |
Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study.Diabetes research and clinical practice, 2008, Volume: 82, Issue:3
Topics: Adult; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathi | 2008 |
Sulphonylureas and cancer: a case-control study.Acta diabetologica, 2009, Volume: 46, Issue:4
Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gliclazide; Glybur | 2009 |
[Childhood-onset diabetes treated with sulphonylureas].Anales de pediatria (Barcelona, Spain : 2003), 2008, Volume: 69, Issue:6
Topics: Child; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Male; Pedigree | 2008 |
Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.Metabolism: clinical and experimental, 2009, Volume: 58, Issue:3
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Pepti | 2009 |
Cinchonain Ib isolated from Eriobotrya japonica induces insulin secretion in vitro and in vivo.Journal of ethnopharmacology, 2009, Jul-15, Volume: 124, Issue:2
Topics: Administration, Oral; Animals; Biflavonoids; Blood Glucose; Catechin; Catechols; Cell Line; Chloroge | 2009 |
Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes.Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:8
Topics: Aged; Amino Acids; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; D | 2009 |
Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes.Diabetes research and clinical practice, 2009, Volume: 85, Issue:2
Topics: Adiponectin; Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypogl | 2009 |
Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes.PloS one, 2009, Aug-18, Volume: 4, Issue:8
Topics: Arginine; Base Sequence; Calpain; Case-Control Studies; Diabetes Mellitus, Type 2; DNA Primers; Gluc | 2009 |
Saxagliptin.Drugs, 2009, Oct-22, Volume: 69, Issue:15
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combinat | 2009 |
Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study.Diabetes research and clinical practice, 2009, Volume: 86, Issue:3
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Cross-Secti | 2009 |
Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus.Diabetes research and clinical practice, 2010, Volume: 88, Issue:1
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Human | 2010 |
Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats.Journal of ethnopharmacology, 2010, Apr-21, Volume: 128, Issue:3
Topics: Alloxan; Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Cecropia Plant; Diabetes Mellitus; Dia | 2010 |
Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus.Metabolism: clinical and experimental, 2010, Volume: 59, Issue:9
Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Azides; Blood Glucose; Body Mass Index; Deoxyuracil Nuc | 2010 |
Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2010, Volume: 118, Issue:4
Topics: Aged, 80 and over; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Female; Glucose; Glybur | 2010 |
Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients.Endocrine journal, 2010, Volume: 57, Issue:6
Topics: Aged; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Family Practice; Gliclazide | 2010 |
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.Diabetes care, 2010, Volume: 33, Issue:6
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Mi | 2010 |
Type 2 diabetes mellitus with pancreatic beta cell dysfunction in 3 horses confirmed with minimal model analysis.Equine veterinary journal, 2009, Volume: 41, Issue:9
Topics: Animal Feed; Animals; Diabetes Mellitus, Type 2; Diet; Diet Therapy; Female; Glucose Tolerance Test; | 2009 |
Effect of sulfonylurea dose escalation on hemoglobin A1c in Veterans Affairs patients with type 2 diabetes.Acta diabetologica, 2013, Volume: 50, Issue:2
Topics: Aged; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glipizide; Gl | 2013 |
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.Expert opinion on drug safety, 2010, Volume: 9, Issue:5
Topics: Age Factors; Aged; Aged, 80 and over; Blood Glucose Self-Monitoring; Comorbidity; Diabetes Mellitus, | 2010 |
Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.Diabetes care, 2010, Volume: 33, Issue:10
Topics: Aged; Aged, 80 and over; Blood Glucose; Cognition; Diabetes Mellitus, Type 2; Female; Glyburide; Hum | 2010 |
Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.Journal of internal medicine, 2010, Volume: 268, Issue:4
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; | 2010 |
Effect of Cyclea peltata Lam. roots aqueous extract on glucose levels, lipid profile, insulin, TNF-alpha and skeletal muscle glycogen in type 2 diabetic rats.Indian journal of experimental biology, 2010, Volume: 48, Issue:5
Topics: Animals; Blood Glucose; Cyclea; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Eva | 2010 |
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.Nature immunology, 2010, Volume: 11, Issue:10
Topics: Amyloid; Animals; Carrier Proteins; Cells, Cultured; Dendritic Cells; Diabetes Mellitus, Type 2; Gly | 2010 |
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry.Diabetes research and clinical practice, 2010, Volume: 90, Issue:3
Topics: Aged; Asian People; Cohort Studies; Diabetes Mellitus, Type 2; Female; Gliclazide; Glipizide; Glybur | 2010 |
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:6
Topics: Aged; Aged, 80 and over; Canada; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Follow-Up | 2011 |
More reasons to say goodbye to glyburide.The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:11
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Myocardial Infarction | 2010 |
Comparison of two sulfonylureas with high and low myocardial K(ATP) channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes.Diabetologia, 2011, Volume: 54, Issue:2
Topics: Animals; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Glycogen; Lactic Acid; Male; Myocardial I | 2011 |
INS VNTR class genotype and the function of isolated human islets.Nutrition, metabolism, and cardiovascular diseases : NMCD, 2011, Volume: 21, Issue:3
Topics: Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Gene | 2011 |
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients.Diabetes research and clinical practice, 2011, Volume: 92, Issue:1
Topics: Aged; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Ag | 2011 |
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007.Clinical pharmacology and therapeutics, 2011, Volume: 89, Issue:3
Topics: Decision Making, Organizational; Diabetes Mellitus, Type 2; Drug Approval; Female; Glyburide; Glycat | 2011 |
Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients.European journal of clinical pharmacology, 2011, Volume: 67, Issue:8
Topics: Alleles; Amplified Fragment Length Polymorphism Analysis; Aryl Hydrocarbon Hydroxylases; Cohort Stud | 2011 |
Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats.Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:3
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Feeding Beha | 2011 |
Neonatal chemical hypoglycemia in newborns from pregnancies complicated by type 2 and gestational diabetes mellitus - the importance of neonatal ponderal index.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2012, Volume: 25, Issue:3
Topics: Birth Weight; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Diabetes, Gestational; Femal | 2012 |
An abundant, truncated human sulfonylurea receptor 1 splice variant has prodiabetic properties and impairs sulfonylurea action.Cellular and molecular life sciences : CMLS, 2012, Volume: 69, Issue:1
Topics: Alternative Splicing; Animals; ATP-Binding Cassette Transporters; Calcium; Chlorocebus aethiops; COS | 2012 |
Fixed dose combination diabetes medicines - usage in the Australian veteran population.Australian family physician, 2011, Volume: 40, Issue:10
Topics: Aged; Aged, 80 and over; Australia; Diabetes Mellitus, Type 2; Drug Combinations; Drug Prescriptions | 2011 |
Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico.International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:1
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Foll | 2012 |
Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.Pharmacogenetics and genomics, 2012, Volume: 22, Issue:3
Topics: ATP-Binding Cassette Transporters; Chlorpropamide; Cyclohexanes; Diabetes Mellitus, Type 2; Gene Exp | 2012 |
Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service.Arquivos brasileiros de endocrinologia e metabologia, 2011, Volume: 55, Issue:9
Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Family Practice; Female; Glyburide; Health Ca | 2011 |
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:8
Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glyburide; Humans; Hy | 2012 |
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:9
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; K | 2012 |
Glycaemic control and cost analysis when changing from gliclazide co-administered with metformin to pre-combined glibenclamide-metformin tablets in type 2 diabetes mellitus.The Medical journal of Malaysia, 2012, Volume: 67, Issue:1
Topics: Blood Glucose; Costs and Cost Analysis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female | 2012 |
Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death.Basic & clinical pharmacology & toxicology, 2012, Volume: 111, Issue:4
Topics: Animals; Cell Death; Cell Line; Cluster Analysis; Diabetes Mellitus, Type 2; Gene Regulatory Network | 2012 |
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:1
Topics: Blood Glucose; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dr | 2013 |
Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population.Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:12
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathi | 2012 |
Effect of Trigonella foenum-graecum seed powder on the antioxidant levels of high fat diet and low dose streptozotocin induced type II diabetic rats.European review for medical and pharmacological sciences, 2012, Volume: 16 Suppl 3Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Di | 2012 |
Evaluating insulin secretagogues in a humanized mouse model with functional human islets.Metabolism: clinical and experimental, 2013, Volume: 62, Issue:1
Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Ex | 2013 |
Preclinical evaluation of hypoglycemic activity of Ipomoea digitata tuber in streptozotocin-induced diabetic rats.Journal of basic and clinical physiology and pharmacology, 2013, Volume: 24, Issue:1
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes | 2013 |
Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study.Clinical therapeutics, 2002, Volume: 24, Issue:9
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therap | 2002 |
Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.Clinical therapeutics, 2002, Volume: 24, Issue:9
Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type | 2002 |
Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes.Metabolism: clinical and experimental, 2002, Volume: 51, Issue:11
Topics: Animals; Area Under Curve; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Diabetes Me | 2002 |
Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide.Diabetes care, 2002, Volume: 25, Issue:12
Topics: Androstadienes; Cell Culture Techniques; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Glyburi | 2002 |
Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).Diabetes, 2002, Volume: 51 Suppl 3Topics: Animals; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Drug Hypersensitivity; Glyburide; Hepatocy | 2002 |
Impairment of myocardial protection in type 2 diabetic patients.The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:2
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Chest Pain; Diabetes Mellitus, Type 2; Electro | 2003 |
Treatment of type 2 diabetes: inadequate assessment of oral antidiabetic combinations.Prescrire international, 2003, Volume: 12, Issue:63
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Glycated | 2003 |
Slow response to loss of glycemic control in type 2 diabetes mellitus.The American journal of managed care, 2003, Volume: 9, Issue:3
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Disease Management; Drug Therapy, Combination | 2003 |
Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.European journal of clinical pharmacology, 2003, Volume: 59, Issue:2
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; | 2003 |
The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.Current medical research and opinion, 2003, Volume: 19, Issue:3
Topics: Administration, Oral; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Combinations; Gl | 2003 |
Urinary PC-1 and N-acetyl-beta-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide.Annals of clinical biochemistry, 2003, Volume: 40, Issue:Pt 3
Topics: Acetylglucosaminidase; Administration, Oral; Adult; Aged; Creatinine; Diabetes Mellitus, Type 2; Fem | 2003 |
Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.PharmacoEconomics, 2003, Volume: 21, Issue:11
Topics: Carbamates; Cohort Studies; Decision Trees; Diabetes Mellitus, Type 2; Direct Service Costs; Drug Co | 2003 |
A comparison of costs for four oral antidiabetic regimens within a managed care population.Managed care interface, 2003, Volume: 16, Issue:7
Topics: Administration, Oral; Adolescent; Adult; Aged; California; Carbamates; Cohort Studies; Data Interpre | 2003 |
Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.Diabetologia, 2003, Volume: 46, Issue:11
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Platelets; Cholesterol; Cyclic GMP; D | 2003 |
Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.Diabetes, obesity & metabolism, 2003, Volume: 5, Issue:6
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Female; Glybur | 2003 |
Acarbose for patients with hypertension and impaired glucose tolerance.JAMA, 2003, Dec-17, Volume: 290, Issue:23
Topics: Acarbose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucose Intolerance; Glyburide; Humans | 2003 |
Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity.Diabetes, obesity & metabolism, 2004, Volume: 6, Issue:1
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type | 2004 |
Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.Archives of internal medicine, 2004, Mar-08, Volume: 164, Issue:5
Topics: Antihypertensive Agents; Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Diabetes Mellitus | 2004 |
Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency.Diabetes research and clinical practice, 2004, Volume: 64, Issue:3
Topics: Anemia, Hemolytic; Black People; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Sched | 2004 |
Retained capacity of glucose-mediated insulin secretion in patients with type 2 diabetes mellitus inversely correlates with the duration of diabetes.Diabetes research and clinical practice, 2004, Volume: 64, Issue:3
Topics: Administration, Oral; Adolescent; Adult; Blood Glucose; Body Mass Index; Chronic Disease; Diabetes M | 2004 |
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.Diabetes research and clinical practice, 2004, Volume: 64, Issue:3
Topics: Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Chronic Disease; Diabetes Mellitus, Typ | 2004 |
Octreotide treatment for sulfonylurea-induced hypoglycaemia.The Medical journal of Australia, 2004, May-17, Volume: 180, Issue:10
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemia; Hypogly | 2004 |
Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.Diabetes, nutrition & metabolism, 2004, Volume: 17, Issue:1
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Fe | 2004 |
Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapy.The Journal of the Association of Physicians of India, 2003, Volume: 51Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglobin; Humans | 2003 |
Refractory hypoglycemia from ciprofloxacin and glyburide interaction.Journal of toxicology. Clinical toxicology, 2004, Volume: 42, Issue:3
Topics: Aged; Anti-Infective Agents; Blood Glucose; Ciprofloxacin; Diabetes Mellitus, Type 2; Diet; Drug Int | 2004 |
An unusual case of hypoglycemia in a diabetic patient.Annals of emergency medicine, 2004, Volume: 44, Issue:4
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Diabetes Mellitus, Type 2; Drug Inte | 2004 |
Role of early insulin secretion in postglucose-loading hyperglycaemia and postfat-loading hyperlipidaemia: comparing nateglinide and glibenclamide for acute effects on insulin secretion in OLETF rats.Diabetes, obesity & metabolism, 2004, Volume: 6, Issue:6
Topics: Adipose Tissue; Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Dietary Fats; Gene | 2004 |
Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis.Nature medicine, 2005, Volume: 11, Issue:3
Topics: Animals; Coenzyme A Ligases; Diabetes Mellitus, Type 2; Dietary Fats; Fat Emulsions, Intravenous; Fa | 2005 |
The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.The Journal of clinical investigation, 2005, Volume: 115, Issue:4
Topics: Animals; Calcium; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Female; Gene Expression Regulatio | 2005 |
[Nothing here follows protocol F. Elderly diabetic patients are not "DMP qualified"].MMW Fortschritte der Medizin, 2005, Feb-03, Volume: 147, Issue:5
Topics: Aged; Blood Glucose; Comorbidity; Contraindications; Diabetes Mellitus, Type 2; Diabetic Foot; Diabe | 2005 |
[Use of oral lipid-lowering drugs in patients with type-2 diabetes mellitus].Atencion primaria, 2005, Apr-30, Volume: 35, Issue:7
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Metfo | 2005 |
Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.British journal of clinical pharmacology, 2005, Volume: 60, Issue:1
Topics: Aged; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Cytochrome P-450 CYP2C9; Diabetes Mellitu | 2005 |
Antidiabetic activity and toxicity of Zizyphus spina-christi leaves.Journal of ethnopharmacology, 2005, Oct-03, Volume: 101, Issue:1-3
Topics: Animals; Aorta; Blood Glucose; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Glyburide; Hypogly | 2005 |
The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2005, Volume: 10, Issue:3
Topics: Analysis of Variance; Angina Pectoris; Chi-Square Distribution; Chronic Disease; Coronary Angiograph | 2005 |
Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.Cardiovascular research, 2006, Feb-01, Volume: 69, Issue:2
Topics: Adenosine; Adrenergic alpha-Agonists; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitu | 2006 |
Willingness to pay for inhaled insulin: a contingent valuation approach.PharmacoEconomics, 2005, Volume: 23, Issue:12
Topics: Administration, Inhalation; Administration, Oral; Adult; Canada; Diabetes Mellitus, Type 1; Diabetes | 2005 |
[Hardly any hypoglycemias, constant weight--and still cost effective].MMW Fortschritte der Medizin, 2005, Nov-24, Volume: 147, Issue:47
Topics: Body Weight; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Drugs, Generic; Glyburide; Humans; Hy | 2005 |
Insulin glargine and educational intervention in patients with type 2 diabetes in clinical practice: long-term improvement in glycaemic control without weight gain.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2006, Volume: 114, Issue:1
Topics: Administration, Oral; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glybu | 2006 |
Apparent resolution of type 2 diabetes mellitus after initiation of potent antiretroviral therapy in a man from Africa with HIV infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, May-15, Volume: 42, Issue:10
Topics: Antiretroviral Therapy, Highly Active; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburi | 2006 |
Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes.European journal of clinical investigation, 2006, Volume: 36, Issue:4
Topics: Biomarkers; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemogl | 2006 |
[Molecular biology and diabetes: where to now?].Vnitrni lekarstvi, 2006, Volume: 52, Issue:3
Topics: Adolescent; Age of Onset; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin | 2006 |
[Glibenclamide instead of insulin: a new chance for MODY 3 type diabetes patients: case report].Vnitrni lekarstvi, 2006, Volume: 52, Issue:3
Topics: Adolescent; Age of Onset; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Hepatoc | 2006 |
Patient characteristics not described.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Jun-20, Volume: 174, Issue:13
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Metformin; Patient Selection; Sul | 2006 |
Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats.Endocrine, 2006, Volume: 29, Issue:2
Topics: Adipose Tissue; Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Glucose Tolerance T | 2006 |
Improvement of type 2 diabetes in a lung cancer patient treated with Erlotinib.Diabetes care, 2006, Volume: 29, Issue:7
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diabetes Mellitus, Type 2; Erlotinib Hydrochloride; Female; Gl | 2006 |
Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat.Diabetes, 2006, Volume: 55, Issue:8
Topics: Animals; Blotting, Western; Diabetes Mellitus, Type 2; Fever; Glucose Tolerance Test; Glyburide; HSP | 2006 |
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.Heart (British Cardiac Society), 2007, Volume: 93, Issue:3
Topics: Blood Glucose; Blood Pressure; Case-Control Studies; Coronary Circulation; Coronary Disease; Diabete | 2007 |
Effects of anthocyanidin derivative (HK-008) on relaxation in rat perfused mesenterial bed.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2006, Volume: 42, Issue:2-3
Topics: Acetylcholine; Animals; Anthocyanins; Antioxidants; Aorta, Thoracic; Blood Glucose; Diabetes Mellitu | 2006 |
Thiazolidinediones for initial treatment of type 2 diabetes?The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23
Topics: Algorithms; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Metformin; Rosiglitaz | 2006 |
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.Diabetes care, 2007, Volume: 30, Issue:2
Topics: Administration, Inhalation; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insul | 2007 |
Alteration of vascular reactivity in diabetic human mammary artery and the effects of thiazolidinediones.The Journal of pharmacy and pharmacology, 2006, Volume: 58, Issue:12
Topics: Aged; Cromakalim; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combina | 2006 |
A comparative study of the effects of hypoglycemic agents on serum electrolytes in the diabetic patients.Pakistan journal of pharmaceutical sciences, 2007, Volume: 20, Issue:1
Topics: Administration, Oral; Blood Glucose; Calcium; Diabetes Mellitus, Type 2; Drug Therapy, Combination; | 2007 |
The effects of metformin and glibenclamide on glucose metabolism, counter-regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity.Diabetic medicine : a journal of the British Diabetic Association, 2007, Volume: 24, Issue:6
Topics: Adult; Blood Glucose; Blood Pressure; Brazil; Case-Control Studies; Cholesterol; Diabetes Mellitus, | 2007 |
Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.Diabetes/metabolism research and reviews, 2007, Volume: 23, Issue:6
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; | 2007 |
Glycemic durability of monotherapy for diabetes.The New England journal of medicine, 2007, Mar-29, Volume: 356, Issue:13
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Metformi | 2007 |
Prevalence of cardiovascular events in diabetic patients taking sulphonylureas: need for assessment.JPMA. The Journal of the Pakistan Medical Association, 2007, Volume: 57, Issue:3
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Pakistan | 2007 |
[Status of glitazones in treatment of type 2 diabetes mellitus].Der Internist, 2007, Volume: 48, Issue:7
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Disease Management; Drug Costs; Drug Therapy, C | 2007 |
[ADOPT study. Glitazone controls diabetes progression].MMW Fortschritte der Medizin, 2007, Volume: 149, Issue:1-2
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Glyburide; Glycated Hemoglobin; Human | 2007 |
[ADOPT study: Reevaluation of antidiabetic drugs. Control of diabetes].MMW Fortschritte der Medizin, 2007, Apr-12, Volume: 149, Issue:15
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Disease Progression; Glyburide; | 2007 |
[Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions].MMW Fortschritte der Medizin, 2007, Apr-12, Volume: 149, Issue:15
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Humans; H | 2007 |
Glibenclamide--what dose?South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2007, Volume: 97, Issue:7
Topics: Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Utilization; Glyburide; Humans; Hy | 2007 |
Polymorphonuclear leukocyte function in type-2 diabetes mellitus patients and its correlation with glycaemic control.Nepal Medical College journal : NMCJ, 2007, Volume: 9, Issue:2
Topics: Adult; Aged; Blood Glucose; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Fema | 2007 |
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.Pediatric diabetes, 2008, Volume: 9, Issue:3 Pt 1
Topics: Birth Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glybu | 2008 |
Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?Diabetes care, 2008, Volume: 31 Suppl 2Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glyburide; Humans; Hypogl | 2008 |
Choosing first-line therapy for management of type 2 diabetes.American family physician, 2008, Jan-01, Volume: 77, Issue:1
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazol | 2008 |
Sitagliptin: new drug. Type 2 diabetes: limited efficacy, too many unknown risks.Prescrire international, 2008, Volume: 17, Issue:93
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therap | 2008 |
Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation.Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:11
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavanones; Gluc | 2008 |
Antihyperglycaemic potential of the water-ethanol extract of Kalanchoe crenata (Crassulaceae).Journal of natural medicines, 2008, Volume: 62, Issue:1
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Ty | 2008 |
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.Diabetes, obesity & metabolism, 2008, Volume: 10 Suppl 1Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; France; Glipi | 2008 |
Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus.Clinical therapeutics, 1984, Volume: 6, Issue:5
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Beta-Globulins; beta-Thromboglobulin; Blood Glucose; Blood Plat | 1984 |
Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1983, Volume: 15, Issue:9
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; | 1983 |
The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.Diabetes, 1984, Volume: 33, Issue:4
Topics: Adipose Tissue; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; | 1984 |
Clinical pharmacology of glipizide.The American journal of medicine, 1983, Nov-30, Volume: 75, Issue:5B
Topics: Biological Availability; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Glipizide; Glybur | 1983 |
Changes in platelet aggregation caused by glyburide in diabetic patients.Clinical therapeutics, 1984, Volume: 6, Issue:3
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glyburide; Humans; | 1984 |
Hyperglycaemic clamp and insulin binding to isolated monocytes before and after glibenclamide treatment of mild type II diabetics.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1984, Volume: 16, Issue:5
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose; Glyburide; Glycated Hemoglobin; Humans; I | 1984 |
Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.Acta medica Scandinavica, 1984, Volume: 215, Issue:5
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Food; Glipizide; Glyburi | 1984 |
Metformin and glibenclamide: comparative risks.British medical journal (Clinical research ed.), 1984, Aug-04, Volume: 289, Issue:6440
Topics: Acidosis; Aged; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemia; Lactates; Metformin; Ris | 1984 |
Glyburide gets approval at last.RN, 1984, Volume: 47, Issue:8
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans | 1984 |
[Effect of glibenclamide therapy on the plasma insulin level in non-insulin-dependent diabetes].Zhonghua yi xue za zhi, 1984, Volume: 64, Issue:3
Topics: Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Insulin; Male | 1984 |
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.Diabetes, 1984, Volume: 33, Issue:9
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glyburide; Humans; I | 1984 |
Control of hypoglycemia by the Biostator.Israel journal of medical sciences, 1984, Volume: 20, Issue:8
Topics: Aged; Computers; Diabetes Mellitus, Type 2; Female; Glucose; Glyburide; Heart Failure; Humans; Hypog | 1984 |
The new oral antidiabetic drugs.American family physician, 1984, Volume: 30, Issue:5
Topics: Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Sulfonyl | 1984 |
Preventive and therapeutic effects of gliclazide on diabetic retinopathy: comparison with glibenclamide treatment.The Tohoku journal of experimental medicine, 1983, Volume: 141 SupplTopics: Adult; Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Gliclazide; Glyburide; Humans; | 1983 |
[Experience with diamicron treatment of diabetics].Klinicheskaia meditsina, 1984, Volume: 62, Issue:11
Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Evaluation; Dru | 1984 |
Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function.Annals of internal medicine, 1995, Dec-15, Volume: 123, Issue:12
Topics: Adenosine Triphosphate; Adult; Aged; Calcium; Cytosol; Diabetes Mellitus, Type 2; Female; Glyburide; | 1995 |
[Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].Medizinische Klinik (Munich, Germany : 1983), 1995, Oct-15, Volume: 90, Issue:10
Topics: Adult; Aged; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Do | 1995 |
Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes.Journal of clinical pharmacology, 1995, Volume: 35, Issue:7
Topics: Adolescent; Adult; Aged; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetes | 1995 |
[Insulin, glibenclamide plus acarbose in diabetes mellitus?].Deutsche medizinische Wochenschrift (1946), 1995, Nov-17, Volume: 120, Issue:46
Topics: Acarbose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide | 1995 |
Insulin-dependent diabetes of pregnancy treated with the combination of sulfonylurea and insulin.Israel journal of medical sciences, 1995, Volume: 31, Issue:10
Topics: Adult; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetes, Gestational; Drug Administrat | 1995 |
Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma.Acta diabetologica, 1995, Volume: 32, Issue:1
Topics: Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Forensic Medicine; | 1995 |
Drug interaction induces hypoglycemia.The Journal of family practice, 1995, Volume: 40, Issue:6
Topics: Diabetes Mellitus, Type 2; Drug Interactions; Enalapril; Female; Glyburide; Humans; Hypertension; Hy | 1995 |
Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control.Diabetes care, 1994, Volume: 17, Issue:10
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Evoked Potentials, Visua | 1994 |
Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM.Diabetes care, 1994, Volume: 17, Issue:11
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glyburide; Half-Life; Huma | 1994 |
Control of diabetes during rehabilitation for diabetic stroke.The Tohoku journal of experimental medicine, 1994, Volume: 173, Issue:4
Topics: Aged; Blood Glucose; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diet Therapy; Female; Gly | 1994 |
Hypoglycaemic--hemiplegia.The Journal of the Association of Physicians of India, 1994, Volume: 42, Issue:6
Topics: Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; Glyburide; Hemiplegia; Humans; Hypoglyce | 1994 |
The effects of glyburide and insulin on the decreased beta-adrenergic responsiveness of the gastrointestinal tract in rats with non-insulin-dependent diabetes.General pharmacology, 1994, Volume: 25, Issue:7
Topics: Albuterol; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diges | 1994 |
A case of diabetes following tibolone therapy.Maturitas, 1994, Volume: 19, Issue:1
Topics: Anabolic Agents; Blood Glucose; Climacteric; Combined Modality Therapy; Diabetes Mellitus, Type 2; D | 1994 |
The effect of hyperglycaemia on the absorption of glibenclamide in patients with non-insulin-dependent diabetes mellitus.European journal of clinical pharmacology, 1994, Volume: 47, Issue:1
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hyperglycemia; Intestinal Absorpt | 1994 |
Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages.Atherosclerosis, 1994, Volume: 105, Issue:2
Topics: Adult; Animals; Cells, Cultured; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, | 1994 |
[Comparison of oral administration of glibenlamide in blood glucose control 30 min before or during breakfast].Zhonghua hu li za zhi = Chinese journal of nursing, 1993, Volume: 28, Issue:8
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Male; Middle Aged | 1993 |
The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics.European journal of clinical pharmacology, 1993, Volume: 45, Issue:5
Topics: Aged; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Femal | 1993 |
Potassium channel blockade and acute myocardial infarction: implications for management of the non-insulin requiring diabetic patient.European heart journal, 1993, Volume: 14, Issue:12
Topics: Adenosine Triphosphate; Animals; Coronary Vessels; Diabetes Mellitus, Type 2; Dogs; Glyburide; Guine | 1993 |
Slow elimination of glyburide in NIDDM subjects.Diabetes care, 1994, Volume: 17, Issue:2
Topics: Adult; Aged; Creatinine; Diabetes Mellitus, Type 2; Female; Glyburide; Half-Life; Humans; Male; Meta | 1994 |
Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.Biochimica et biophysica acta, 1994, May-11, Volume: 1191, Issue:2
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Diabetes Mellitus, Type 2; Gly | 1994 |
[Non-insulin-dependent diabetics with secondary failure: insulin therapy at bedtime combined with glibenclamide].Revista medica de Chile, 1993, Volume: 121, Issue:10
Topics: Aged; Analysis of Variance; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Drug T | 1993 |
Hypoglycemia caused by maprotiline in a patient taking oral antidiabetics.The Annals of pharmacotherapy, 1994, Volume: 28, Issue:3
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glyburide; Humans; | 1994 |
Effect of the sulfonylurea glyburide on superoxide dismutase activity in alloxan-induced diabetic rat hepatocytes.Diabetes research and clinical practice, 1994, Volume: 22, Issue:2-3
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fem | 1994 |
Drug treatment during Ramadan. Don't be complacent about diabetes.BMJ (Clinical research ed.), 1993, Sep-25, Volume: 307, Issue:6907
Topics: Diabetes Mellitus, Type 2; Fasting; Glyburide; Humans; Hypoglycemia; Islam | 1993 |
[C-peptide levels in secondary sulfonylurea resistant diabetics].Orvosi hetilap, 1993, Dec-26, Volume: 134, Issue:52
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 2; Drug Resistance; Female; Glucagon; Glyburide; Humans; In | 1993 |
Plasma lipids and VLDL composition in male non-insulin dependent diabetic patients: relation with HbA1c levels.Research communications in chemical pathology and pharmacology, 1993, Volume: 80, Issue:2
Topics: Administration, Oral; Apolipoproteins; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; Glycated | 1993 |
Transient state of NIDDM in a patient with AIDS.Diabetes care, 1993, Volume: 16, Issue:6
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Blood Glucose; C-P | 1993 |
Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.The Journal of clinical endocrinology and metabolism, 1993, Volume: 77, Issue:2
Topics: Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Calorimetry, Indirect; Diabetes Mellitu | 1993 |
Remission of active diabetic hepatitis after correction of hyperglycemia.Liver, 1993, Volume: 13, Issue:4
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Hepatitis; Humans; Hypergly | 1993 |
[Mofebutazone--evaluation of possible interaction with glibenclamide].Fortschritte der Medizin, 1993, Aug-20, Volume: 111, Issue:22-23
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Glucose; Diabetes Mellit | 1993 |
The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.Diabetes care, 1993, Volume: 16, Issue:1
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Eating; Female; Gastric Inhibitory Polypeptid | 1993 |
Inappropriate use of high-dose glyburide to treat uncontrolled type 2 diabetes mellitus.The Annals of pharmacotherapy, 1993, Volume: 27, Issue:2
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Drug Overdose; Female; Glyburide; Humans; Hypoglyce | 1993 |
Pemphigus vulgaris precipitated by glibenclamide therapy.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1993, Volume: 22, Issue:2
Topics: Aged; Azathioprine; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Fluconazole | 1993 |
Bedtime insulin added to daytime sulfonylureas improves glycemic control in uncontrolled type II diabetes.Clinical pharmacology and therapeutics, 1993, Volume: 53, Issue:3
Topics: Adult; Aged; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glipizide; Gly | 1993 |
Type II diabetes: who has the keys?The Journal of laboratory and clinical medicine, 1993, Volume: 121, Issue:4
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans | 1993 |
Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide.The Journal of laboratory and clinical medicine, 1993, Volume: 121, Issue:4
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Insulin; Male; Mid | 1993 |
The effects of glibenclamide on glucose homeostasis and lipoprotein metabolism in poorly controlled type 2 diabetes.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1993, Volume: 25, Issue:2
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Glyburide; Glycerol; | 1993 |
The effects of glyburide and insulin on the cardiac performance in rats with non-insulin-dependent diabetes mellitus.General pharmacology, 1993, Volume: 24, Issue:1
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dri | 1993 |
Modulation of the insulinotropic action of glibenclamide and glimepiride by nutrient secretagogues in pancreatic islets from normoglycemic and hyperglycemic rats.Biochemical pharmacology, 1993, May-05, Volume: 45, Issue:9
Topics: Animals; B-Lymphocytes; Calcium; Carbon Dioxide; Diabetes Mellitus, Type 2; Glucose; Glyburide; Hype | 1993 |
Effect of war on glycemic control in type II diabetic patients.Diabetes care, 1993, Volume: 16, Issue:5
Topics: Adult; Aged; Blood Glucose; Croatia; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglob | 1993 |
[Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].Polski tygodnik lekarski (Warsaw, Poland : 1960), 1993, Volume: 48 Suppl 1Topics: Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Sulfonylurea Compound | 1993 |
Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM.British journal of haematology, 1996, Volume: 92, Issue:1
Topics: Acute Disease; Anemia, Hemolytic; Diabetes Mellitus, Type 2; Glucosephosphate Dehydrogenase Deficien | 1996 |
Rat inwardly rectifying potassium channel Kir6.2: cloning electrophysiological characterization, and decreased expression in pancreatic islets of male Zucker diabetic fatty rats.Biochemical and biophysical research communications, 1996, Mar-27, Volume: 220, Issue:3
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Base Sequence; Cattle; Cell Line; Cloning, Mol | 1996 |
Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics.Lancet (London, England), 1975, Feb-01, Volume: 1, Issue:7901
Topics: Adult; Blood Glucose; Body Weight; Chlorpropamide; Diabetes Mellitus, Type 2; Glyburide; Humans; Hyp | 1975 |
Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend.The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:7
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glyburide; Hum | 1996 |
[Drug-induced asterixis amplified by relative hypoglycemia].Der Nervenarzt, 1996, Volume: 67, Issue:4
Topics: Antipsychotic Agents; Clozapine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug T | 1996 |
Fatal toxic intrahepatic cholestasis secondary to glibenclamide.Diabetes care, 1996, Volume: 19, Issue:4
Topics: Aged; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis, Intrahepatic; Diabetes Mellitus, | 1996 |
ATP-sensitive potassium channels, transmural ischemia and the ECG implications for the non-insulin dependent diabetic patient?Cardiovascular research, 1996, Volume: 31, Issue:5
Topics: Adenosine Triphosphate; Diabetes Mellitus, Type 2; Electrocardiography; Glyburide; Humans; Myocardia | 1996 |
The riddle of formycin A insulinotropic action.Biochemical and molecular medicine, 1996, Volume: 57, Issue:1
Topics: Adenosine; Animals; Calcium; Diabetes Mellitus, Type 2; Diazoxide; Female; Formycins; Glucose; Glybu | 1996 |
Influence of oral antidiabetic treatment on electrocardiac alterations induced by myocardial infarction.Diabetes research and clinical practice, 1996, Volume: 31 SupplTopics: Action Potentials; Administration, Oral; Aged; Anti-Arrhythmia Agents; Case-Control Studies; Diabete | 1996 |
Metabolic effects of dietary sucrose and fructose in type II diabetic subjects.Diabetes care, 1996, Volume: 19, Issue:11
Topics: Adult; Aged; Blood Glucose; Blood Proteins; Body Weight; C-Peptide; Chlorpropamide; Cholesterol; Cho | 1996 |
Maximal dose glyburide therapy in markedly symptomatic patients with type II diabetes: a new use for an old friend.The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:11
Topics: Acid-Base Equilibrium; Bicarbonates; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agen | 1996 |
Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1996, Volume: 50, Issue:6-7
Topics: Acarbose; Aged; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glucos | 1996 |
[Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].Minerva endocrinologica, 1996, Volume: 21, Issue:3
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Combinatio | 1996 |
Relationship between home glucose testing and hemoglobin Alc in type II diabetes patients.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, May-01, Volume: 54, Issue:9
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Glyburide; Gly | 1997 |
Effect of the sulfonylurea glyburide on superoxide dismutase in streptozotocin-induced diabetic rat muscle.General pharmacology, 1997, Volume: 28, Issue:5
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gly | 1997 |
Pharmacokinetics of oral glyburide in subjects with non-insulin-dependent diabetes mellitus and renal failure.American journal of kidney diseases : the official journal of the National Kidney Foundation, 1997, Volume: 29, Issue:6
Topics: Administration, Oral; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hy | 1997 |
Glibenclamide and liver disease.Diabetes care, 1997, Volume: 20, Issue:7
Topics: Biopsy; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypogl | 1997 |
Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice.Pharmacology, 1997, Volume: 54, Issue:4
Topics: Animals; Blood Glucose; Body Weight; Carcinoma, Hepatocellular; Cell Division; Diabetes Mellitus, Ty | 1997 |
Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks.Age and ageing, 1997, Volume: 26, Issue:5
Topics: Aged; Aged, 80 and over; Chlorpropamide; Diabetes Mellitus, Type 2; Female; Geriatric Assessment; Gl | 1997 |
Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats.European journal of pharmacology, 1997, Sep-24, Volume: 335, Issue:2-3
Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Fasting; Female | 1997 |
A retrospective analysis of the efficacy and safety of metformin in the African-American patient.Journal of the National Medical Association, 1997, Volume: 89, Issue:11
Topics: Adult; Aged; Aged, 80 and over; Black People; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, | 1997 |
Action of metformin on erythrocyte membrane fluidity in vitro and in vivo.European journal of pharmacology, 1997, Oct-15, Volume: 337, Issue:1
Topics: Adult; Diabetes Mellitus, Type 2; Erythrocyte Membrane; Fluorescent Dyes; Glyburide; Humans; Hypogly | 1997 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1
Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus | 1997 |
Treatment of NIDDM in youth.Clinical pediatrics, 1998, Volume: 37, Issue:2
Topics: Adolescent; Child; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Japan; | 1998 |
Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.Diabetes, 1998, Volume: 47, Issue:3
Topics: Animals; Binding Sites; Binding, Competitive; Blood Glucose; Carbamates; Cohort Studies; Culture Tec | 1998 |
Atypical ketoacidosis in type 2 diabetes.Hospital practice (1995), 1998, Mar-15, Volume: 33, Issue:3
Topics: Adult; Ambulatory Care; Clinical Protocols; Diabetes Complications; Diabetes Mellitus; Diabetes Mell | 1998 |
In most poorly controlled glyburide-treated type 2 diabetic patients drug withdrawal causes further increase in glycemia not accompanied by changes in insulin secretion.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1998, Volume: 30, Issue:2
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemogl | 1998 |
Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.Diabetes care, 1998, Volume: 21, Issue:4
Topics: Animals; Aorta; Arteriosclerosis; Cattle; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; C | 1998 |
Glibenclamide-induced cholestasis.The Western journal of medicine, 1998, Volume: 168, Issue:4
Topics: Cholangiopancreatography, Endoscopic Retrograde; Cholestasis, Intrahepatic; Diabetes Mellitus, Type | 1998 |
Hypoglycemia from glipizide and glyburide.JAMA, 1998, May-13, Volume: 279, Issue:18
Topics: Aged; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Hypoglycemia; Risk | 1998 |
[Diagnostic pitfalls in sulfonylurea-induced neuroglycopenic syndrome with hemiparesis, dysphasia and somnolence].Medizinische Klinik (Munich, Germany : 1983), 1998, Jun-15, Volume: 93, Issue:6
Topics: Aged; Aged, 80 and over; Aphasia; Cerebral Infarction; Consciousness Disorders; Diabetes Mellitus, T | 1998 |
[Effect of sugar-reducing therapy on renal function in patients with type II diabetes mellitus].Klinicheskaia meditsina, 1998, Volume: 76, Issue:6
Topics: Adult; Aged; beta 2-Microglobulin; Blood Glucose; Diabetes Mellitus, Type 2; Glomerular Filtration R | 1998 |
Lactic acidosis with therapeutic metformin blood level in a low-risk diabetic patient.Diabetes care, 1998, Volume: 21, Issue:8
Topics: Acidosis, Lactic; Adult; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Hu | 1998 |
Commercially sponsored supplements.Diabetic medicine : a journal of the British Diabetic Association, 1998, Volume: 15, Issue:8
Topics: Acarbose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Peri | 1998 |
Chorea in hyperglycemia.Diabetes care, 1998, Volume: 21, Issue:10
Topics: Aged; Aged, 80 and over; Brain; Chorea; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gl | 1998 |
[Preparation and utility of glibenclamide suppository for hospital use].Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1998, Volume: 118, Issue:9
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Hypoglycemic Agents; Rabbits; | 1998 |
[24 years later....].La Revue de medecine interne, 1998, Volume: 19, Issue:10
Topics: Cell Membrane; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic | 1998 |
Restricting home glucose-monitoring strips in patients taking oral antidiabetic agents.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-01, Volume: 55, Issue:23
Topics: Administration, Oral; Adult; Arizona; Blood Glucose; Blood Glucose Self-Monitoring; Creatinine; Diab | 1998 |
Review of management of type 2 diabetes mellitus.Journal of clinical pharmacy and therapeutics, 1998, Volume: 23, Issue:6
Topics: Aged; Body Weight; Contraindications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; | 1998 |
[Necrotizing cellulitis of the hand and forearm in a hospitalized diabetic patient].Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17, Issue:1
Topics: Aged; Amputation, Surgical; Arm; Cellulitis; Dermatomycoses; Diabetes Mellitus, Type 2; Female; Glyb | 1999 |
Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.The Netherlands journal of medicine, 1999, Volume: 54, Issue:2
Topics: Aged; Biomarkers; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Therapy, Combinati | 1999 |
A short term cost-effectiveness model for oral antidiabetic medicines in Europe.PharmacoEconomics, 1998, Volume: 13, Issue:3
Topics: Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Europe; Glyburide; Humans; Hypoglycemic Agents; In | 1998 |
[Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].Revue d'epidemiologie et de sante publique, 1999, Volume: 47, Issue:1
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Hypoglycemic | 1999 |
Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.Clinical and experimental hypertension (New York, N.Y. : 1993), 1999, Volume: 21, Issue:3
Topics: Animals; Blood Glucose; Blood Pressure; Catecholamines; Chromans; Diabetes Mellitus, Type 2; Glucose | 1999 |
Impaired beta-adrenoceptor mediated venodilation in patients with diabetes mellitus.British journal of clinical pharmacology, 1999, Volume: 47, Issue:4
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Glyburide; Humans; Isoproterenol; Male; Middle Aged; Nitrogl | 1999 |
The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta cells is mediated by a 65-kDa mdr-like P-glycoprotein.Proceedings of the National Academy of Sciences of the United States of America, 1999, May-11, Volume: 96, Issue:10
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Antibodies, Monoclonal; ATP Binding Casse | 1999 |
Glibenclamide-induced hypoglycemic coma in 51 older patients with type 2 diabetes mellitus.Journal of the American Geriatrics Society, 1999, Volume: 47, Issue:5
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diabetic Coma; Female; Glyburide; Humans; Hypogl | 1999 |
Glimepiride: new preparation. Just another hypoglycaemic sulphonylurea agent.Prescrire international, 1998, Volume: 7, Issue:36
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evalua | 1998 |
Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues.Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 1999, Volume: 51, Issue:4-5
Topics: Animals; Antioxidants; Brain; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; | 1999 |
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas.Diabetic medicine : a journal of the British Diabetic Association, 1999, Volume: 16, Issue:7
Topics: Aged; Aged, 80 and over; Case-Control Studies; Confidence Intervals; Diabetes Mellitus, Type 2; Emer | 1999 |
Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus.Journal of internal medicine, 1999, Volume: 246, Issue:3
Topics: Aged; Arrhythmias, Cardiac; Diabetes Mellitus, Type 2; Electrocardiography; Female; Glucose Clamp Te | 1999 |
Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:9
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Epinephrine; Female; | 1999 |
Bone amyloidoma in a diabetic patient with morbid obesity.Diabetes & metabolism, 1999, Volume: 25, Issue:3
Topics: Amyloidosis; Bone Diseases; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gl | 1999 |
Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients.Diabetes care, 1999, Volume: 22, Issue:10
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Exercise; Exercise Test; Glucagon; Glyburide; | 1999 |
The effect of octreotide on glucose and insulin levels in a patient with type 2 diabetes on glibenclamide.Diabetes & metabolism, 1999, Volume: 25, Issue:4
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Hemostatics; Humans; Hypoglycemi | 1999 |
Increased glucose intolerance related to digoxin treatment in patients with type 2 diabetes mellitus.Journal of internal medicine, 1999, Volume: 246, Issue:4
Topics: Aged; Aged, 80 and over; Blood Glucose; Cardiotonic Agents; Diabetes Mellitus, Type 2; Digoxin; Fata | 1999 |
Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)European heart journal, 2000, Volume: 21, Issue:3
Topics: Aged; Case-Control Studies; Creatine Kinase; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Femal | 2000 |
Human anti-murine antibodies interfere with CPR assays performed with commercial kits.Diabetes research and clinical practice, 2000, Volume: 48, Issue:2
Topics: Aged; Animals; Antibodies; Antibodies, Monoclonal; Artifacts; C-Peptide; Child, Preschool; Diabetes | 2000 |
A type 2 diabetic patient with liver dysfunction due to human insulin.Diabetes research and clinical practice, 2000, Volume: 49, Issue:1
Topics: Alanine Transaminase; Alkaline Phosphatase; Antibodies, Viral; Aspartate Aminotransferases; Bilirubi | 2000 |
Glyburide-induced hemolysis in myelodysplastic syndrome.Diabetes care, 2000, Volume: 23, Issue:1
Topics: Aged; Diabetes Mellitus, Type 2; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Male; Myelodyspl | 2000 |
Acute rhabdomyolysis associated with troglitazone.Diabetes care, 2000, Volume: 23, Issue:3
Topics: Chromans; Creatine Kinase; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; | 2000 |
Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris.Clinical cardiology, 2000, Volume: 23, Issue:7
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Administration, Oral; Adult; Angina Pectoris; Blo | 2000 |
Glyburide-ciprofloxacin interaction with resistant hypoglycemia.Annals of emergency medicine, 2000, Volume: 36, Issue:2
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic N | 2000 |
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:7
Topics: Adult; Amino Acid Substitution; Chlorpropamide; Diabetes Mellitus, Type 2; DNA Transposable Elements | 2000 |
Does holiday hypoglycaemia exist?Panminerva medica, 2000, Volume: 42, Issue:1
Topics: Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middl | 2000 |
Glyburide/metformin (Glucovance) for type 2 diabetes.The Medical letter on drugs and therapeutics, 2000, Nov-13, Volume: 42, Issue:1092
Topics: Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Glyburide; Hypoglyce | 2000 |
Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:1
Topics: Aged; Biomarkers; Black or African American; Black People; Blood Glucose; C-Peptide; Combined Modali | 2001 |
Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea.Annals of internal medicine, 2001, Feb-20, Volume: 134, Issue:4
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Drug Synergism; Glyburide; | 2001 |
Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control.Diabetes, obesity & metabolism, 2000, Volume: 2, Issue:4
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Erythrocytes; Female; Glyburide; Humans; Hypoglycemic Agen | 2000 |
A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3
Topics: Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Butyrates; Calcium; Calcium Channe | 2001 |
Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.Diabetes research and clinical practice, 2001, Volume: 53, Issue:1
Topics: Catalase; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Diab | 2001 |
Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up.Clinical cardiology, 2001, Volume: 24, Issue:2
Topics: Administration, Oral; Coronary Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glybur | 2001 |
Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.Diabetes technology & therapeutics, 2000,Autumn, Volume: 2, Issue:3
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Glyburide; Humans; Hypoglycemic Agents; | 2000 |
Management of type 2 diabetes: long-awaited evidence of benefits after blood sugar control.Prescrire international, 1999, Volume: 8, Issue:43
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemia; Hypoglycemic Ag | 1999 |
[Proliferative activity of the gastric epithelium: changes due to therapy in patients with association of gastric ulcer and diabetes mellitus].Khirurgiia, 2001, Issue:6
Topics: Adult; Age Factors; Aged; Data Interpretation, Statistical; Diabetes Complications; Diabetes Mellitu | 2001 |
Differences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population-based study.Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:4
Topics: Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans | 2001 |
Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in Type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:7
Topics: Biomarkers; Blood Glucose; Calibration; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemog | 2001 |
Treatment of type 2 diabetes: the sooner, the better.Journal of internal medicine, 2001, Volume: 250, Issue:3
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Glyburide; Glycat | 2001 |
Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.Metabolism: clinical and experimental, 2001, Volume: 50, Issue:11
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2001 |
Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.Managed care (Langhorne, Pa.), 2001, Volume: 10, Issue:2 Suppl
Topics: Counseling; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Glyburide; Huma | 2001 |
Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease.Heart (British Cardiac Society), 2002, Volume: 87, Issue:1
Topics: Administration, Oral; Blood Glucose; Coronary Angiography; Coronary Circulation; Coronary Stenosis; | 2002 |
Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis.Diabetes care, 2002, Volume: 25, Issue:2
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Diabetes Mellit | 2002 |
Vascular K(ATP) channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes.Clinical science (London, England : 1979), 2002, Volume: 102, Issue:3
Topics: Acarbose; Acetylcholine; Cross-Over Studies; Diabetes Mellitus, Type 2; Diazoxide; Dipyridamole; Dou | 2002 |
A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients.Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:12
Topics: Adult; Agaricales; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemia; Hypogl | 2001 |
Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes.Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:6
Topics: Aged; Biotransformation; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; | 2001 |
Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success.Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:4
Topics: Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Glycated Hemoglob | 2002 |
[Effective reduction of the HbA1c level, fewer side effects. First fixed combination for type 2 diabetic patients].MMW Fortschritte der Medizin, 2002, Mar-28, Volume: 144, Issue:13
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Glycated | 2002 |
Coefficient of failure: a methodology for examining longitudinal beta-cell function in Type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:6
Topics: Chlorpropamide; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglyce | 2002 |
The effect of sulphonylurea therapy on serum total cholesterol and high density lipoprotein cholesterol.Journal of the Indian Medical Association, 1992, Volume: 90, Issue:10
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Ma | 1992 |
Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides.The Journal of the Association of Physicians of India, 1992, Volume: 40, Issue:10
Topics: Biguanides; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Combinations; Female; Gli | 1992 |
Falciparum malaria-induced hypoglycaemia in a diabetic patient.Postgraduate medical journal, 1992, Volume: 68, Issue:798
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucose Solution, Hypertonic; Glyburide; Humans; Hypoglyce | 1992 |
The dawn phenomenon and diabetes control in treated NIDDM and IDDM patients.Diabetes research and clinical practice, 1992, Volume: 16, Issue:3
Topics: Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gluca | 1992 |
Potentiation of hypoglycemic response of glibenclamide by piroxicam in rats and humans.Indian journal of experimental biology, 1992, Volume: 30, Issue:4
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glyburide; Humans; Hyp | 1992 |
Program reimburses pharmacists who counsel patients on glyburide product.American journal of hospital pharmacy, 1992, Volume: 49, Issue:11
Topics: Diabetes Mellitus, Type 2; Drug Industry; Glyburide; Humans; Patient Education as Topic; Pharmacists | 1992 |
[Median-term (4 months) treatment with glibenclamide + metformin substituting for glibenclamide + fenformin lowers the lacticemia levels in type-2 diabetics (NIDDM)].La Clinica terapeutica, 1992, Volume: 141, Issue:12
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Therapy, Combination; Female; | 1992 |
Relationship between blood pressure and in vivo action of insulin in type II (non-insulin-dependent) diabetic subjects.Metabolism: clinical and experimental, 1992, Volume: 41, Issue:3
Topics: Antihypertensive Agents; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Femal | 1992 |
[Combination therapy with insulin and sulfonylurea compounds in type II diabetes mellitus--long-term results].Wiener klinische Wochenschrift, 1992, Volume: 104, Issue:5
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combinat | 1992 |
Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents.European journal of clinical pharmacology, 1992, Volume: 42, Issue:3
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combinati | 1992 |
Beneficial effect of a low glycaemic index diet in type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 1992, Volume: 9, Issue:5
Topics: Aged; Biomarkers; Blood Glucose; C-Peptide; Cholesterol; Creatinine; Diabetes Mellitus, Type 2; Diet | 1992 |
Impaired glucose sensitivity of ATP-sensitive K+ channels in pancreatic beta-cells in streptozotocin-induced NIDDM rats.Diabetes, 1992, Volume: 41, Issue:7
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Blood Glucose; Cells, Cultured; Diabetes Mellitus | 1992 |
Adverse effect on diabetes control of concomitant glibenclamide and tolbutamide.Lancet (London, England), 1991, Mar-09, Volume: 337, Issue:8741
Topics: Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Glyburide; Humans; Male; Mi | 1991 |
Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus.Diabetes research and clinical practice, 1991, Volume: 14, Issue:2
Topics: Arizona; Chlorpropamide; Diabetes Mellitus, Type 2; Glyburide; Hospitalization; Humans; Hypoglycemia | 1991 |
[Diabetes mellitus and its complications in Japan. The determination of glycemic threshold for the regression or prevention of diabetic microangiopathies, and insulin injection regimen to establish strict glycemic control in NIDDM].Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Sep-10, Volume: 80, Issue:9
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; | 1991 |
Glibenclamide-induced cholestasis.Journal of hepatology, 1991, Volume: 13, Issue:3
Topics: Biopsy; Cholestasis; Diabetes Mellitus, Type 2; Glyburide; Humans; Liver; Male; Middle Aged | 1991 |
Correction of fasting hyperglycaemia with insulin or sulphonylurea lowers fasting ketone levels, but does not alter resting or post-glucose energy expenditure in non insulin dependent diabetes. Differences between the OGTT and the glucose clamp.Diabetes research (Edinburgh, Scotland), 1991, Volume: 18, Issue:3
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Energy Metabolism; Fasting; Female; Glucose; Gl | 1991 |
[The psychological aspects of diabetics with the secondary failure of sulfonylurea therapy].Deutsche medizinische Wochenschrift (1946), 1991, Jan-18, Volume: 116, Issue:3
Topics: Adaptation, Psychological; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Emotions; Female; | 1991 |
Metabolic control in diabetic subjects in three Swedish areas with high, medium, and low sales of antidiabetic drugs.Diabetes care, 1991, Volume: 14, Issue:1
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Comb | 1991 |
Extrapancreatic insulin effect of glibenclamide.European journal of clinical pharmacology, 1991, Volume: 40, Issue:4
Topics: Administration, Oral; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Food; Glyburide; | 1991 |
Crossover comparison of maximum dose glyburide and glipizide.Southern medical journal, 1991, Volume: 84, Issue:6
Topics: Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gli | 1991 |
[A comparison between glibenclamide and glipizide in the treatment of type II diabetes].Zhonghua nei ke za zhi, 1991, Volume: 30, Issue:2
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Male; Middle Aged; P | 1991 |
Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus.The American journal of medicine, 1991, Jun-24, Volume: 90, Issue:6A
Topics: Adipose Tissue; Adult; Diabetes Mellitus, Type 2; Female; Glucose; Glyburide; Humans; Insulin; Lipid | 1991 |
[Hypoglycemia in type II diabetic patients].Medizinische Klinik (Munich, Germany : 1983), 1990, Mar-15, Volume: 85, Issue:3
Topics: Adult; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemia; Insulin; Male; Middle Age | 1990 |
Flexible glibenclamide dosage in Nigerian diabetic patients.Tropical doctor, 1990, Volume: 20, Issue:2
Topics: Diabetes Mellitus, Type 2; Drug Administration Schedule; Glyburide; Humans; Nigeria | 1990 |
Glyburide: new insights into its effects on the beta cell and beyond--introduction.The American journal of medicine, 1990, Aug-20, Volume: 89, Issue:2A
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Islets of Langerhans | 1990 |
Effects of glyburide on in vivo insulin-mediated glucose disposal.The American journal of medicine, 1990, Aug-20, Volume: 89, Issue:2A
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucose; Glyburide; Huma | 1990 |
Acute actions of sulfonylurea drugs during long-term treatment of NIDDM.Diabetes care, 1990, Volume: 13 Suppl 3Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Insulin; Male; | 1990 |
Failure of glyburide and insulin treatment to decrease leucine flux in obese type II diabetic patients.International journal of obesity, 1990, Volume: 14, Issue:8
Topics: Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Insulin; Leucine; Middle Aged; Obesity | 1990 |
Unaltered drug metabolizing enzyme systems in type II diabetes mellitus before and during glyburide therapy.Journal of clinical pharmacology, 1990, Volume: 30, Issue:10
Topics: Adult; Aminopyrine; Breath Tests; Caffeine; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type | 1990 |
Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy.Metabolism: clinical and experimental, 1990, Volume: 39, Issue:11
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Epinephrine; Fast | 1990 |
Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy.The American journal of medicine, 1990, Volume: 89, Issue:6
Topics: Captopril; Diabetes Mellitus, Type 2; Enalapril; Glyburide; Humans; Hypertension; Hypoglycemia; Male | 1990 |
Changes in peripheral insulin concentrations in non insulin dependent diabetes during treatment. Assessment by mathematical applications.The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:9
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Eating; Evaluation Studies as Topic; Female; Follow | 1990 |
Combined insulin-glibenclamide therapy of NIDDM patients in primary health care. A follow-up study of its compliance and efficacy and a review of the literature.Scandinavian journal of primary health care, 1990, Volume: 8, Issue:4
Topics: Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Comb | 1990 |
Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:7
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Insulin Resistance; Middle A | 1990 |
Hypoglycemia masquerading as repeated focal stereotyped neurological deficit (a case report).Journal of postgraduate medicine, 1990, Volume: 36, Issue:4
Topics: Aged; Diabetes Mellitus, Type 2; Diagnosis, Differential; Glyburide; Humans; Hypoglycemia; Male | 1990 |
Recovery of Staub Effect and amelioration of insulin secretion defects after glyburide treatment in non-insulin-dependent diabetes.Diabetes research (Edinburgh, Scotland), 1990, Volume: 15, Issue:2
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Glucose Tolerance Test; Glyburide; Glycated Hemog | 1990 |
[Treatment of newly diagnosed type II diabetic patients with special reference to prescribing glibenclamide in low doses].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1989, Mar-01, Volume: 44, Issue:5
Topics: Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Dose-Response Rel | 1989 |
[Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].Deutsche medizinische Wochenschrift (1946), 1989, Jul-07, Volume: 114, Issue:27
Topics: Aged; Animals; Biguanides; Cricetinae; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburi | 1989 |
Apolipoprotein assays: methodological considerations and studies in non-insulin-dependent diabetes treated by diet, glibenclamide and insulin.Scandinavian journal of clinical and laboratory investigation, 1989, Volume: 49, Issue:3
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Diabetes Mellitus, Type 2; Diet, Di | 1989 |
Usefulness of anaerobic threshold in estimating intensity of exercise for diabetics.Diabetes research and clinical practice, 1989, May-15, Volume: 6, Issue:4
Topics: Adult; Anaerobiosis; Blood Glucose; Buformin; Diabetes Mellitus, Type 2; Exercise; Female; Glucagon; | 1989 |
Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:3
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glyburide; Humans; Hyperglycem | 1989 |
Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide.Diabetes care, 1989, Volume: 12, Issue:8
Topics: C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; F | 1989 |
Sulphonylureas (specifically glibenclamide) and their correct dosage.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1989, Sep-16, Volume: 76, Issue:6
Topics: Aged; Diabetes Mellitus, Type 2; Glyburide; Humans; Middle Aged | 1989 |
Ocular effects of second generation oral hypoglycemic agents.Journal of the American Optometric Association, 1989, Volume: 60, Issue:11
Topics: Administration, Oral; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; Humans; Lens, Cryst | 1989 |
Glibenclamide steady state plasma levels during concomitant vinpocetine administration in type II diabetic patients.Arzneimittel-Forschung, 1989, Volume: 39, Issue:11
Topics: Blood Glucose; Dementia; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glyburide; Humans; Ma | 1989 |
Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.Diabetes research (Edinburgh, Scotland), 1989, Volume: 11, Issue:1
Topics: Alcohol Drinking; Apolipoproteins; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diab | 1989 |
[Effect of antidiabetics on post-exercise alaninemia in patients with non-insulin-dependent diabetes mellitus (type 2)].Polskie Archiwum Medycyny Wewnetrznej, 1989, Volume: 81, Issue:4
Topics: Adult; Alanine; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Exercise; E | 1989 |
[The correlation of glycohemoglobin (HbA1) with the parameters of blood glucose control during the treatment of diabetes mellitus].Vutreshni bolesti, 1989, Volume: 28, Issue:6
Topics: Adult; Blood Glucose; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Th | 1989 |
[Drug interactions in geriatrics. Apropos a case].Atencion primaria, 1989, Volume: 6, Issue:5
Topics: Aged; Clofibrate; Diabetes Mellitus, Type 2; Drug Synergism; Glyburide; Humans; Hypoglycemia; Male | 1989 |
The effect of improved control on blood filtration properties and non-enzymatic glycosylation of erythrocyte proteins in type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 1989, Volume: 6, Issue:6
Topics: Diabetes Mellitus, Type 2; Diet, Diabetic; Erythrocyte Membrane; Filtration; Glyburide; Glycated Hem | 1989 |
Acute effect of glibenclamide upon red cell transglutaminase activity in diabetic patients.Journal of endocrinological investigation, 1987, Volume: 10, Issue:6
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Endocytosis; Erythrocytes; Glyburide; Humans; Insul | 1987 |
Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication).Hormone and metabolic research. Supplement series, 1985, Volume: 15Topics: 6-Ketoprostaglandin F1 alpha; Aged; Antigens; beta-Thromboglobulin; Blood Platelets; Diabetes Mellit | 1985 |
[Pellagra-like changes following glibenclamide treatment in a patient with diabetes mellitus and vitiligo].Dermatologische Monatschrift, 1988, Volume: 174, Issue:1
Topics: Diabetes Mellitus, Type 2; Drug Eruptions; Female; Glyburide; Humans; Middle Aged; Pellagra; Vitilig | 1988 |
Kidney disease in KK mice: effect of glyburide.Advances in experimental medicine and biology, 1988, Volume: 246Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephrop | 1988 |
Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.Clinical therapeutics, 1988, Volume: 10, Issue:4
Topics: Adult; Aged; Apolipoproteins; Apolipoproteins A; Apolipoproteins B; beta-Thromboglobulin; Blood Gluc | 1988 |
Influence of verapamil on human glucose tolerance.The American journal of cardiology, 1986, Feb-26, Volume: 57, Issue:7
Topics: Administration, Oral; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Drug Synergism; Female; Gluco | 1986 |
Glipizide and glyburide.North Carolina medical journal, 1986, Volume: 47, Issue:3
Topics: Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Kinetics; Sulfonylurea C | 1986 |
[Secondary failure of oral antidiabetics. Value of intravenous insulin infusions].Diabete & metabolisme, 1986, Volume: 12, Issue:1
Topics: Administration, Oral; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy | 1986 |
Interindividual variation in the absorption of glibenclamide in man.Acta endocrinologica, 1986, Volume: 111, Issue:4
Topics: Absorption; Administration, Oral; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; | 1986 |
Treatment of type II diabetes.British medical journal (Clinical research ed.), 1986, May-10, Volume: 292, Issue:6530
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemia | 1986 |
Insulin secretion and erythrocyte insulin binding in Cape coloured non-obese non-insulin-dependent diabetes in the young: effects of sulphonylurea therapy.Diabetes research and clinical practice, 1986, Volume: 2, Issue:1
Topics: Adult; Diabetes Mellitus, Type 2; Erythrocytes; Ethnicity; Glyburide; Humans; Insulin; Male; South A | 1986 |
Massive glibenclamide overdose without hypoglycaemia in a man with diabetes after partial pancreatectomy.Human toxicology, 1986, Volume: 5, Issue:4
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemia; Male; Middle Aged; Pancreatectomy; Posto | 1986 |
Glibenclamide induced prolonged hypoglycaemia.Age and ageing, 1986, Volume: 15, Issue:3
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose; Glyburide; Humans; Hypoglycemia; In | 1986 |
Appraisal of glibenclamide administration before, with, or after the meal.Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1986, Volume: 85, Issue:5
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glyburide; Humans; Ins | 1986 |
Potentiation by previous nutrients of glibenclamide-induced insulin release in man. An effect which is counteracted by meal-induced retardation of drug absorption.Scandinavian journal of clinical and laboratory investigation, 1986, Volume: 46, Issue:6
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Food; Glyburide; Humans; Inje | 1986 |
The antidiabetic activity of aloes: preliminary clinical and experimental observations.Hormone research, 1986, Volume: 24, Issue:4
Topics: Aloe; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glyburide; | 1986 |
[Daonil and Hemi-Daonil].Soins; la revue de reference infirmiere, 1986, Issue:487-488
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans | 1986 |
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.Diabetes, 1987, Volume: 36, Issue:2
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glybu | 1987 |
Glyburide does not alter thyroid function.Diabetes research (Edinburgh, Scotland), 1986, Volume: 3, Issue:9
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; Humans; Male; Middle Aged; Prospective St | 1986 |
Remission in non-insulin dependent diabetes.Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1987, Volume: 70 Suppl 2Topics: Adult; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Male; Middle Aged; Remission Induction | 1987 |
[Possibility of transferring patients with type-II diabetes mellitus treated with small doses of sulfonylurea preparations to diet therapy].Vutreshni bolesti, 1987, Volume: 26, Issue:2
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus, Type 2; Female; Glucagon; | 1987 |
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.Diabetes, 1987, Volume: 36, Issue:11
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Gl | 1987 |
Effect of glyburide in type II diabetes mellitus. Studies of monocyte membrane fluidity, lipid composition, and insulin binding.Diabetes, 1987, Volume: 36, Issue:12
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; Humans; Kinetics; Membrane Fluidity; Membrane L | 1987 |
Combination therapy of insulin plus oral agent in the elderly diabetic.Journal of the American Geriatrics Society, 1988, Volume: 36, Issue:3
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combinatio | 1988 |
A system approach to pharmacodynamics. II: Glyburide pharmacodynamics and estimation of optimal drug delivery.Journal of pharmaceutical sciences, 1988, Volume: 77, Issue:1
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glyburide; Humans | 1988 |
[Pharmacokinetic and clinical study on glibenclamide].Zhonghua yi xue za zhi, 1987, Volume: 67, Issue:10
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Male; Metabolic Clearance Rate; M | 1987 |
Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:3
Topics: Blood Glucose; Blood Urea Nitrogen; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Energy | 1988 |
Photosensitivity due to glyburide.Photo-dermatology, 1988, Volume: 5, Issue:1
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Erythema; Glyburide; Humans; Male; Middle Aged; | 1988 |
[Insulin therapy of obese diabetic patients? Consequences for the evaluation of insulin secretion and metabolic behavior].Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1987, Volume: 47, Issue:6
Topics: Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Energy Meta | 1987 |
[Hemorheologic, metabolic and blood coagulation changes in diabetics in treatment with sulfanyl ureas].Minerva medica, 1988, Volume: 79, Issue:5
Topics: Blood Coagulation; Blood Viscosity; Diabetes Mellitus, Type 2; Erythrocyte Deformability; Gliclazide | 1988 |
[Glibenclamide (Maninil)-induced hypoglycemia--a case report].Zeitschrift fur arztliche Fortbildung, 1988, Volume: 82, Issue:3
Topics: Blood Glucose; Cholecystectomy; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemia; Male; Mi | 1988 |
[Effect of glibenclamide on lipid metabolism in non-insulin-dependent diabetic patients].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1988, Mar-01, Volume: 43, Issue:5
Topics: Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diab | 1988 |
Use oral hypoglycemics with caution...Geriatrics, 1988, Volume: 43, Issue:8
Topics: Aged; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Interactions; Glyburide; Humans; Hypoglycemia; | 1988 |
Red blood cell and plasma fatty acid composition in diabetes mellitus.Metabolism: clinical and experimental, 1988, Volume: 37, Issue:8
Topics: Diabetes Mellitus, Type 2; Erythrocytes; Fatty Acids; Glyburide; Humans; Male; Middle Aged | 1988 |
[Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].Vutreshni bolesti, 1988, Volume: 27, Issue:2
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Glipizide; Glyburide | 1988 |
Antilipolytic effect of insulin in non-insulin-dependent diabetes mellitus after conventional treatment with diet and sulfonylurea.Acta medica Scandinavica, 1988, Volume: 224, Issue:5
Topics: Adipose Tissue; Adult; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Glucose Tolerance Test; Gl | 1988 |
In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes.Diabetes research (Edinburgh, Scotland), 1988, Volume: 8, Issue:2
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fem | 1988 |
[Effects of different regimens of drug administration on the absorption and plasma concentration of glibenclamide].Zhonghua nei ke za zhi, 1988, Volume: 27, Issue:9
Topics: Administration, Oral; Aged; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Male; Middle Aged | 1988 |
[Comparison of the hypoglycemic effect of 2 presentations--of glibenclamide].La Tunisie medicale, 1988, Volume: 66, Issue:12
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Human | 1988 |
[Effect of insulin therapy on lipoprotein concentrations in secondary sulfonylurea treatment failures in menopause].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1988, Dec-01, Volume: 43, Issue:23
Topics: Aged; Arteriosclerosis; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mel | 1988 |
Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.Diabetes research (Edinburgh, Scotland), 1988, Volume: 9, Issue:2
Topics: Aged; Blood Proteins; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycat | 1988 |
[Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].Terapevticheskii arkhiv, 1988, Volume: 60, Issue:12
Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Gliclazide; Gluco | 1988 |
Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.Clinical therapeutics, 1988, Volume: 10, Issue:4
Topics: Adult; Aged; Apolipoproteins; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, | 1988 |
Reversal of insulin resistance in adipose tissue of non-insulin-dependent diabetics by treatment with diet and sulphonylurea.Acta endocrinologica, 1985, Volume: 108, Issue:1
Topics: Adipose Tissue; Diabetes Mellitus, Type 2; Female; Glipizide; Glucose; Glyburide; Humans; Insulin; I | 1985 |
Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent.The American journal of the medical sciences, 1985, Volume: 289, Issue:4
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glybur | 1985 |
Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone.Archives of internal medicine, 1985, Volume: 145, Issue:6
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Energy Intake; Fasting; Fem | 1985 |
Clinical, cellular, and physiologic effects of glyburide in non-insulin-dependent diabetes mellitus.The American journal of medicine, 1985, Sep-20, Volume: 79, Issue:3B
Topics: Biological Transport; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glucose; Glyburide; H | 1985 |
Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitus.The American journal of medicine, 1985, Sep-20, Volume: 79, Issue:3B
Topics: Adipose Tissue; Blood Glucose; Diabetes Mellitus, Type 2; Glucose; Glucose Tolerance Test; Glyburide | 1985 |
Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.The American journal of medicine, 1985, Sep-20, Volume: 79, Issue:3B
Topics: Adipose Tissue; Animals; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mel | 1985 |
Fat cells: model system to investigate molecular mechanism(s) of sulfonylurea-potentiated glucose transport.The American journal of medicine, 1985, Sep-20, Volume: 79, Issue:3B
Topics: Adipose Tissue; Biological Transport; Blood Glucose; Cell Membrane; Cytochalasin B; Diabetes Mellitu | 1985 |
Effects of glyburide therapy on lipoproteins in non-insulin-dependent diabetes mellitus.The American journal of medicine, 1985, Sep-20, Volume: 79, Issue:3B
Topics: Cholesterol; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Evaluation Studies as Topic; Glyburide; H | 1985 |
Pharmacokinetics of glibenclamide: heterogeneity in its absorption.Medical journal of Osaka University, 1985, Volume: 35, Issue:3-4
Topics: Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Female; Glyburide; H | 1985 |
The second generation sulfonylureas: glipizide and glyburide.The Diabetes educator, 1985,Fall, Volume: 11, Issue:3
Topics: Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Insulin; Sulfonylurea Compounds | 1985 |
Metformin and the sulphonylureas: the comparative risk.Hormone and metabolic research. Supplement series, 1985, Volume: 15Topics: Acidosis; Diabetes Mellitus, Type 2; Drug Interactions; Glyburide; Humans; Hypoglycemia; Metformin; | 1985 |
Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.Diabetologia, 1985, Volume: 28, Issue:11
Topics: Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Glucose; Glyburide; Human | 1985 |
Apolipoproteins in diabetes mellitus.Monographs on atherosclerosis, 1985, Volume: 13Topics: Adult; Apolipoproteins; Bezafibrate; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus | 1985 |